<SEC-DOCUMENT>0000950103-25-013455.txt : 20251021
<SEC-HEADER>0000950103-25-013455.hdr.sgml : 20251021
<ACCEPTANCE-DATETIME>20251021160056
ACCESSION NUMBER:		0000950103-25-013455
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20251021
DATE AS OF CHANGE:		20251021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251407000

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236099_424b2-7852wfps.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 53%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">PRICING SUPPLEMENT dated October 17, 2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">(To the Prospectus dated May 15, 2025,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">the Prospectus Supplement dated May 15, 2025
and</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">the Product Supplement No. WF-1 dated May
20, 2025)</P></TD>
    <TD STYLE="width: 47%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement No. 333-287303</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P></TD></TR>
  <TR>
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="barclays PLC logo" STYLE="height: 42px; width: 179px"></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="padding-right: 4pt; width: 100%; padding-left: 4pt">
    <P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left; color: #BB0826">Global Medium-Term Notes, Series
A</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">
    <P STYLE="color: #BB0826; font: bold 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">$928,000 Market Linked Securities&mdash;Contingent
Fixed Return and Contingent Downside</P>
    <P STYLE="color: #BB0826; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Principal at Risk Securities
Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October
29, 2026</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding-right: 4pt; width: 100%; padding-left: 4pt">
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.25in; text-align: justify; color: white"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Linked
    to the lowest performing of the common stock of Advanced Micro Devices, Inc. and the common stock of NVIDIA Corporation (each referred
    to as an &ldquo;<U>Underlying Stock</U>&rdquo;)</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.25in; text-align: justify; color: white"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Unlike
    ordinary debt securities, the securities do not pay interest or repay a fixed amount of principal at maturity. Instead, the securities
    provide for a maturity payment amount that may be greater than or less than the principal amount of the securities, depending on the performance
    of the lowest performing Underlying Stock. The lowest performing Underlying Stock is the Underlying Stock that has the lowest stock return
    (i.e., the lowest percentage change from its starting price to its ending price). The maturity payment amount will reflect the following
    terms:</FONT></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.5in; color: white; text-align: justify"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">If
    the stock closing price of the lowest performing Underlying Stock increases, remains flat or decreases, but the decrease is not more than
    40%, you will receive the principal amount plus a contingent fixed return of 14.70% of the principal amount.</FONT></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.5in; color: white; text-align: justify"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If
    the <FONT STYLE="color: white">stock closing </FONT>price of the lowest performing Underlying Stock decreases by more than 40%, you will
    have full downside exposure to the decrease in the <FONT STYLE="color: white">stock closing </FONT>price of that Underlying Stock, and
    you will lose more than 40%, and possibly all, of the principal amount of your securities.</FONT></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.25in; text-align: justify; color: white"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Investors
    may lose more than 40%, and possibly all, of the principal amount.</FONT></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.25in; text-align: justify; color: white"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Any
    positive return on the securities at maturity will be limited to the contingent fixed return, even if the ending price of the lowest performing
    Underlying Stock significantly exceeds its starting price; you will not participate in any appreciation of any Underlying Stock.</FONT></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.25in; text-align: justify; color: white"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Your
    return on the securities will depend <B>solely</B> on the performance of the lowest performing Underlying Stock. You will not benefit
    in any way from the performance of the better performing Underlying Stock. Therefore, you will be adversely affected if <B>either Underlying
    Stock </B>performs poorly, even if the other Underlying Stock performs favorably.</FONT></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.25in; text-align: justify; color: white"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Any
    payment on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed
    by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in
    Power (as described on page PS-6 of this pricing supplement) by the relevant U.K. resolution authority, you might not receive any amounts
    owed to you under the securities. See &ldquo;Selected Risk Considerations&rdquo; and &ldquo;Consent to U.K. Bail-in Power&rdquo; in this
    pricing supplement and &ldquo;Risk Factors&rdquo; in the accompanying prospectus supplement.</FONT></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.25in; text-align: justify; color: white"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">No
    periodic interest payments or dividends</FONT></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"></P>
    <P STYLE="color: white; font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.25in; text-align: justify; color: white"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">No
exchange listing; designed to be held to maturity</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">See &ldquo;Additional Information about the
Issuer and the Securities&rdquo; on page PS-4 of this pricing supplement. The securities will have the terms specified in the prospectus
dated May 15, 2025, the prospectus supplement dated May 15, 2025 and the product supplement no. WF-1 dated May 20, 2025, as supplemented
or superseded by this pricing supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities have complex features and
investing in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk
Considerations&rdquo; on page PS-10 herein, &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the product supplement and &ldquo;Risk
Factors&rdquo; beginning on page S-9 of the prospectus supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities constitute our unsecured and
unsubordinated obligations. The securities are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial
Services Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit
insurance agency of the United States, the United Kingdom or any other jurisdiction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Neither the U.S. Securities and Exchange
Commission (the &ldquo;<U>SEC</U>&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined
that this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We may use this pricing supplement in the
initial sale of the securities. In addition, Barclays Capital Inc. or any other of our affiliates may use this pricing supplement in
market resale transactions in any of the securities after their initial sale. Unless we or our agent informs you otherwise in the confirmation
of sale, this pricing supplement is being used in a market resale transaction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the
relevant U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page PS-6 of this pricing supplement.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%; font: bold 10pt Arial, Helvetica, Sans-Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Original Offering Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agent Discount<SUP>(2), (3)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceeds to Barclays Bank PLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$23.25</FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$976.75</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$928,000</FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$21,576</FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$906,424</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(1)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">Our estimated value of the securities on the pricing date, based
on our internal pricing models, is $920.00 per security. The estimated value is less than the original offering price of the securities.
See &ldquo;Additional Information Regarding Our Estimated Value of the Securities&rdquo; on page PS-5 of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(2)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">Wells Fargo Securities, LLC (&ldquo;WFS&rdquo;) and Barclays Capital
Inc. are the agents for the distribution of the securities and are acting as principal. The agent will receive an underwriting discount
of $23.25 per security. Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a
concession of $23.25 per security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;) (the trade name
of the retail brokerage business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network,
LLC), with a selling concession of $17.50 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of
the agent&rsquo;s discount to WFA as a distribution expense fee for each security sold by WFA. See &ldquo;Terms of the Securities&mdash;Supplemental
Plan of Distribution&rdquo; in this pricing supplement for further information.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(3)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">In respect of certain securities sold in this offering, Barclays
Capital Inc. may pay a fee of up to $1.00 per security to selected securities dealers in consideration for marketing and other services
in connection with the distribution of the securities to other securities dealers.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font: bold 12pt Arial, Helvetica, Sans-Serif; text-align: justify">Wells Fargo Securities</TD>
    <TD STYLE="width: 50%; font: bold 12pt Arial, Helvetica, Sans-Serif; text-align: right">Barclays Capital Inc.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: bold 14pt Arial, Helvetica, Sans-Serif; color: #BB0826; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Terms
of the Securities</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR>
    <TD STYLE="border-top: White 1pt solid; padding: 2pt 4pt; width: 21%; border-bottom: White 1pt solid; border-left: White 1pt solid; font: 10pt Georgia, Times, Serif; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issuer:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; vertical-align: top; width: 79%; font: 10pt Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR>
    <TD ROWSPAN="5" STYLE="width: 21%; padding: 2pt 4pt; border-left: White 1pt solid; font: 10pt Georgia, Times, Serif; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market Measures<SUP>1</SUP>:</B></FONT></TD>
    <TD COLSPAN="4" STYLE="padding: 2pt 4pt; font: 10pt Georgia, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The common stock of Advanced Micro Devices, Inc. (the &ldquo;<U>AMD Stock</U>&rdquo;) and the common stock of NVIDIA Corporation (the &ldquo;<U>NVDA Stock</U>&rdquo;) (each referred to as an &ldquo;<U>Underlying Stock</U>,&rdquo; and collectively as the &ldquo;<U>Underlying Stocks</U>&rdquo;). We refer to the issuers of the Market Measures as the &ldquo;<U>Underlying Stock Issuers</U>.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt 4pt; border: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market Measure</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Bloomberg Ticker Symbol</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Starting Price<SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Threshold Price<SUP>(b)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt 4pt; border-left: Black 1pt solid; font: 10pt Georgia, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">AMD Stock</FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">AMD UW&lt;Equity&gt;</FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$233.08</FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$139.848</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt 4pt; border-left: Black 1pt solid; font: 10pt Georgia, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">NVDA Stock</FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">NVDA UW&lt;Equity&gt;</FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$183.22</FONT></TD>
    <TD STYLE="padding: 2pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$109.932</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding: 2pt 4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(a)</SUP> With respect to each Underlying
Stock, the stock closing price of that Underlying Stock on the pricing date</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(b)</SUP> With respect to each Underlying
Stock, 60% of its starting price</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Georgia, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="border-top: white 1pt solid; padding: 2pt 4pt; width: 21%; border-bottom: White 1pt solid; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; vertical-align: top; width: 79%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 17, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 22, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Day<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 26, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stated Maturity Date<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 29, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Principal Amount:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maturity Payment Amount: </B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will be
entitled to receive a cash payment per security in U.S. dollars equal to the maturity payment amount. The &ldquo;<U>maturity payment
amount</U>&rdquo; per security will equal:</P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">if
the ending price of the lowest performing Underlying Stock is greater than or equal to its threshold price: </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">$1,000 + the contingent fixed return; or</P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: -11pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">if
the ending price of the lowest performing Underlying Stock is less than its threshold price: </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">$1,000 + ($1,000 &times; stock return of the lowest
performing Underlying Stock)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the ending price of the lowest performing
Underlying Stock is less than its threshold price, you will lose more than 40%, and possibly all, of the principal amount of your securities
at maturity. Any payment on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank
PLC and is not guaranteed by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the
exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority, you might not receive any amounts owed to you under the
securities.</B></P></TD></TR>
  <TR>
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Lowest Performing Underlying Stock:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The &ldquo;<U>lowest performing Underlying Stock</U>&rdquo; will
be the Underlying Stock with the lowest stock return.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Contingent Fixed Return:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>contingent fixed return</U>&rdquo; is 14.70% of the principal amount ($147.00 per security). The contingent fixed return is payable only if the ending price of the lowest performing Underlying Stock is greater than or equal to its threshold price.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock Return:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &ldquo;<U>stock return</U>&rdquo; with
respect to an Underlying Stock is the percentage change from its starting price to its ending price, measured as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ending price &ndash; starting price</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">starting price</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ending Price:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>ending price</U>&rdquo; of an Underlying Stock will be its stock closing price on the calculation day.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Georgia, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="border-top: white 1pt solid; padding: 2pt 4pt; width: 21%; border-bottom: White 1pt solid; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock Closing Price<SUP>1</SUP>: </B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; width: 79%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">With respect to each Underlying Stock, &ldquo;<U>stock closing price</U>&rdquo; has the meaning set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Certain Definitions&rdquo; in the product supplement. The stock closing price of each Underlying Stock is subject to adjustment through the adjustment factor as described in the product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Additional Terms:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Terms used in this pricing supplement, but not defined herein, will have the meanings ascribed to them in the product supplement, <I>provided</I> that terms used in this pricing supplement, but not defined herein or in the product supplement, will have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Tax Considerations:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For a discussion of the tax considerations relating to ownership and disposition of the securities, see &ldquo;Tax Considerations.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Denominations:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">06746EC60 / US06746EC604</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: White 1pt solid; padding: 2pt 4pt; border-left: White 1pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Supplemental Plan of Distribution:</B></FONT></TD>
    <TD STYLE="padding: 2pt 4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;)
and Barclays Capital Inc. will act as agents for the securities. The agent will receive an underwriting discount of $23.25 per security.
Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession of $23.25 per
security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade name of the retail brokerage
business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), with a selling
concession of $17.50 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of the agent&rsquo;s
discount to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in respect of certain securities
sold in this offering, Barclays may pay a fee of up to $1.00 per security to selected securities dealers in consideration for marketing
and other services in connection with the distribution of the securities to other securities dealers.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC or its affiliate will enter
into swap agreements or related hedge transactions with one of its other affiliates or unaffiliated counterparties in connection with
the sale of the securities. If WFS, Barclays Capital Inc. or an affiliate of either agent participating as a dealer in the distribution
of the securities conducts hedging activities for Barclays Bank PLC in connection with the securities, such agent or participating dealer
will expect to realize a projected profit from such hedging activities, and this projected profit will be in addition to any discount,
concession or fee received in connection with the sale of the securities to you. This additional projected profit may create a further
incentive for the agents or participating dealers to sell the securities to you.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP></SUP></P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>1</SUP> In the case of certain corporate
events related to an Underlying Stock, the calculation agent may adjust the adjustment factor of that Underlying Stock if the calculation
agent determines that the event has a diluting or concentrative effect on the theoretical value of the shares of that Underlying Stock.
Upon the occurrence of certain reorganization events with respect to an Underlying Stock, the calculation agent will make adjustments
to reflect the amount and type of property deliverable for one share of that Underlying Stock as a result of that reorganization event.
An Underlying Stock may be replaced with another stock selected by the calculation agent upon the occurrence of certain replacement stock
events. For more information, see &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment
Events&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>2</SUP> If the calculation day is not a trading
day with respect to either Underlying Stock, the calculation day for each Underlying Stock will be postponed to the next succeeding day
that is a trading day with respect to each Underlying Stock. The calculation day will also be postponed for either Underlying Stock if
a market disruption event occurs with respect to that Underlying Stock on the calculation day as described under &ldquo;General Terms
of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Calculation Day&mdash;Securities Linked to Multiple
Market Measures&rdquo; in the accompanying product supplement. In addition, the stated maturity date will be postponed if that day is
not a business day or if the calculation day is postponed as described under &ldquo;General Terms of the Securities&mdash;Payment Dates&rdquo;
in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information about the Issuer and the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together
with the prospectus dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term
Notes, Series A, of which these securities are a part and the product supplement no. WF-1 dated May 20, 2025. This pricing supplement,
together with the documents listed below, contains the terms of the securities and supersedes all prior or contemporaneous oral statements
as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for
implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things,
the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement and &ldquo;Selected Risk Considerations&rdquo; in
this pricing supplement, as the securities involve risks not associated with conventional debt securities. We urge you to consult your
investment, legal, tax, accounting and other advisors before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the information or terms in this
pricing supplement are different from or inconsistent with the information or terms in the prospectus, prospectus supplement or product
supplement, the information and terms in this pricing supplement will control. To the extent the information or terms in the product supplement
are different from or inconsistent with the information or terms in the prospectus or prospectus supplement, the information and terms
in the product supplement will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus Supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product Supplement No. WF-1 dated May 20, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our SEC file number is 1-10257. As used in this
pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information Regarding Our Estimated Value of the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our internal pricing models take into account
a number of variables and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility,
interest rates and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on
variables, such as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels
at which our benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal
funding rates. Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark
debt securities trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value of the securities on the pricing
date is less than the original offering price of the securities. The difference between the original offering price of the securities
and our estimated value of the securities results from several factors, including any sales commissions to be paid to Barclays Capital
Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees to be allowed or paid to non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the estimated cost
that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may incur in connection
with the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value on the pricing date is not
a prediction of the price at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital
Inc. may buy or sell the securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or
another affiliate of ours intends to offer to purchase the securities in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming that all relevant factors remain constant
after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if
any, and the value that we may initially use for customer account statements, if we provide any customer account statements at all, may
exceed our estimated value on the pricing date for a temporary period expected to be approximately three months after the initial issue
date of the securities because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost
of hedging our obligations under the securities and other costs in connection with the securities that we will no longer expect to incur
over the term of the securities. We made such discretionary election and determined this temporary reimbursement period on the basis of
a number of factors, which may include the tenor of the securities and/or any agreement we may have with the distributors of the securities.
The amount of our estimated costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement
period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue
date of the securities based on changes in market conditions and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We urge you to read the &ldquo;Selected Risk
Considerations&rdquo; beginning on page PS-10 of this pricing supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Consent
to U.K. Bail-in Power</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between us and any holder or beneficial owner of
the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner
of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the U.K. Banking Act 2009, as amended, the
relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority
is satisfied that the resolution conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely
to fail to satisfy the Financial Services and Markets Act 2000 (the &ldquo;<U>FSMA</U>&rdquo;) threshold conditions for authorization
to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that
is a European Economic Area (&ldquo;<U>EEA</U>&rdquo;) or third country institution or investment firm, that the relevant EEA or third
country relevant authority is satisfied that the resolution conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.K. Bail-in Power includes any write-down,
conversion, transfer, modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities into shares or other securities or other obligations
of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the securities of such shares,
securities or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration of the maturity of the securities,
or the amendment of the amount of interest or any other amounts due on the securities, or the dates on which interest or any other amounts
become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation
of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power.
Each holder and beneficial owner of the securities further acknowledges and agrees that the rights of the holders or beneficial owners
of the securities are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by
the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders
or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority in breach of laws applicable in England.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, please see &ldquo;Selected
Risk Considerations&mdash;Risks Relating to the Issuer&mdash;You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is
Exercised by the Relevant U.K. Resolution Authority&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is
failing or likely to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers,
could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Investor
Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all
investors. The securities <I>may</I> be an appropriate investment for you if all of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek a contingent fixed return at maturity
of 14.70% of the principal amount if the ending price of the lowest performing Underlying Stock is greater than or equal to its threshold
price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You anticipate that the ending price of the lowest
performing Underlying Stock will be greater than or equal to its threshold price, and you are willing and able to accept the risk that,
if it is not, you will lose more than 40%, and possibly all, of the principal amount of your securities at maturity. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand that if the ending price of the
lowest performing Underlying Stock is greater than or equal to its threshold price, the return you will receive at maturity will be limited
to the contingent fixed return, regardless of whether, and the extent to which, the ending price of the lowest performing Underlying Stock
exceeds its starting price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the individual
market risk of each Underlying Stock and you understand that poor performance by either Underlying Stock over the term of the securities
may negatively affect your return and will not be offset or mitigated by any positive performance by the other Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the risks
associated with an investment linked to the performance of the lowest performing Underlying Stock, as explained in more detail in the
&ldquo;Selected Risk Considerations&rdquo; section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand and accept that you will not be
entitled to receive dividends or distributions that may be paid to holders of the Underlying Stocks, nor will you have any voting rights
with respect to the Underlying Stocks.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment for which there
will be an active secondary market and you are willing and able to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to consent to the exercise
of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may <I>not</I> be an appropriate
investment for you if <I>any</I> of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that provides for the
full repayment of principal at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You anticipate that the ending price of the lowest
performing Underlying Stock will be less than its threshold price, or you are unwilling or unable to accept the risk that, if it is, you
will lose more than 40%, and possibly all, of the principal amount of your securities at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that provides for full
exposure to the upside performance of the lowest performing Underlying Stock above the contingent fixed return.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the individual
market risk of each Underlying Stock or the risk that poor performance by either Underlying Stock over the term of the securities may
negatively affect your return and will not be offset or mitigated by any positive performance by the other Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the risks
associated with an investment linked to the performance of the lowest performing Underlying Stock, as explained in more detail in the
&ldquo;Selected Risk Considerations&rdquo; section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that entitles you to dividends
or distributions on, or voting rights related to, the Underlying Stocks.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment for which there will be
an active secondary market and/or you are unwilling or unable to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to consent to the
exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>investment in the securities in light of your
particular circumstances. You should also review carefully the &ldquo;Selected Risk Considerations&rdquo; beginning on page PS-10 of this
pricing supplement and the &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the accompanying product supplement and the &ldquo;Risk
Factors&rdquo; beginning on page S-9 of the accompanying prospectus supplement for risks related to an investment in the securities. For
more information about the Underlying Stocks, please see the sections titled &ldquo;The Common Stock of Advanced Micro Devices, Inc.&rdquo;
and &ldquo;The Common Stock of NVIDIA Corporation&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Determining
the Maturity Payment Amount</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will receive
a cash payment per security (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 1: Determine which Underlying Stock is the
lowest performing Underlying Stock. The lowest performing Underlying Stock is the Underlying Stock that has the lowest stock return, calculated
for each Underlying Stock as the percentage change from its starting price to its ending price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 2: Calculate the maturity payment amount
based on the ending price of the lowest performing Underlying Stock, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_005.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Selected
Risk Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant
risks. Investing in the securities is not equivalent to investing directly in either or both Underlying Stocks. Some of the risks that
apply to an investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks relating
to the securities generally in the &ldquo;Risk Factors&rdquo; sections of the product supplement and prospectus supplement. You should
not purchase the securities unless you understand and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Securities
Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>If The Ending Price Of The Lowest Performing
Underlying Stock Is Less Than Its Threshold Price, You Will Lose More Than 40%, And Possibly All, Of The Principal Amount Of Your Securities
At Maturity</B> &mdash; If the ending price of the lowest performing Underlying Stock is less than its threshold price, the maturity payment
amount will be less than the principal amount and you will have full downside exposure to the decrease in the price of that Underlying
Stock from its starting price. The threshold price for each Underlying Stock is 60% of its starting price. For example, if the lowest
performing Underlying Stock has declined by 40.1% from its starting price to its ending price, you will not receive any benefit from the
contingent downside feature and you will lose 40.1% of the principal amount. As a result, you will not receive any protection if the price
of the lowest performing Underlying Stock declines significantly and you may lose more than 40%, and possibly all, of the principal amount
at maturity, even if the price of the lowest performing Underlying Stock is greater than or equal to its starting price or its threshold
price at certain times during the term of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>The Potential Return
On The Securities Is Limited To The Contingent Fixed Return And May Be Lower Than The Return On A Direct Investment In Any Underlying
Stock </B>&mdash; The potential return on the securities is limited to the contingent fixed return, regardless of any appreciation of
any </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Underlying Stock<FONT STYLE="background-color: white">, which may
be significant. Therefore, your return on the securities may be lower than the return on a direct investment in any </FONT>Underlying
Stock<FONT STYLE="background-color: white">.</FONT></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Will Receive The Contingent Fixed Return
Only If The Ending Price Of The Lowest Performing Underlying Stock Is Greater Than Or Equal To Its Threshold Price</B> &mdash; You will
receive the contingent fixed return only if the ending price of the lowest performing Underlying Stock is greater than or equal to its
threshold price. If the ending price of the lowest performing Underlying Stock is less than its threshold price, then you will not receive
the contingent fixed return, and you will suffer a loss on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Periodic Interest Will Be Paid On The Securities
</B>&mdash; No periodic payments of interest will be made on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Are Subject To The Full Risks
Of Each Underlying Stock And Will Be Negatively Affected If Either Underlying Stock Performs Poorly, Even If The Other Underlying Stock
Performs Favorably</B> &mdash; You are subject to the full risks of each Underlying Stock. If either Underlying Stock performs poorly,
you will be negatively affected, even if the other Underlying Stock performs favorably. The securities are not linked to a basket composed
of the Underlying Stocks, where the better performance of one Underlying Stock could offset the poor performance of the other Underlying
Stock. Instead, you are subject to the full risks of whichever Underlying Stock is the lowest performing Underlying Stock. As a result,
the securities are riskier than an alternative investment linked to only one of the Underlying Stocks or linked to a basket composed of
both Underlying Stocks. You should not invest in the securities unless you understand and are willing to accept the full downside risks
of each Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Your Return On The Securities Will Depend
Solely On The Performance Of The Lowest Performing Underlying Stock, And You Will Not Benefit In Any Way From The Performance Of The Better
Performing Underlying Stock</B> &mdash; Your return on the securities will depend solely on the performance of the lowest performing Underlying
Stock. Although it is necessary for each Underlying Stock to close at or above its threshold price on the calculation day in order for
you to be repaid the principal amount of your securities at maturity, you will not benefit in any way from the performance of the better
performing Underlying Stock. The securities may underperform an alternative investment linked to a basket composed of the Underlying Stocks,
since in such case the performance of the better performing Underlying Stock would be blended with the performance of the lowest performing
Underlying Stock, resulting in a better return than the return of the lowest performing Underlying Stock alone.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Will Be Subject To Risks Resulting From
The Relationship Between The Underlying Stocks</B> &mdash; The correlation of a pair of Underlying Stocks represents a statistical measurement
of the degree to which the returns of those Underlying Stocks are similar to each other over a given period in terms of timing and direction.
By investing in the securities, you assume the risk that the returns of the Underlying Stocks will not be correlated. The less correlated
the Underlying Stocks, the more likely it is that any one of the Underlying Stocks will be performing poorly at any time over the term
of the securities. All that is necessary for the securities to perform poorly is for one of the Underlying Stocks to perform poorly; the
performance of the better performing Underlying Stock is not relevant to your return on the securities. It is impossible to predict what
the relationship between the Underlying Stocks will be over the term of the securities. The Underlying Stocks may represent different
equity markets, and those equity markets may not perform similarly over the term of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Any Payment On The Securities Will Be Determined
Based On The Stock Closing Prices Of The Underlying Stocks On The Dates Specified</B> &mdash; Any payment on the securities will be determined
based on the stock closing prices of the Underlying </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Stocks on the dates
specified. You will not benefit from any more favorable values of the Underlying Stocks determined at any other time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Owning The Securities Is Not The Same As Owning
Either Or Both Of The Underlying Stocks</B> &mdash; The return on your securities may not reflect the return you would realize if you
actually owned either or both of the Underlying Stocks. For instance, as a holder of the securities, you will not have voting rights or
rights to receive cash dividends or other distributions or any other rights that holders of either Underlying Stock would have.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Assurance That The Investment View Implicit
In The Securities Will Be Successful</B> &mdash; It is impossible to predict whether and the extent to which the price of either Underlying
Stock will rise or fall. There can be no assurance that the ending price of either Underlying Stock will not be less than its threshold
price. The price of each Underlying Stock will be influenced by complex and interrelated political, economic, financial and other factors
that affect that Underlying Stock. You should be willing to accept the downside risks associated with equities in general and each Underlying
Stock in particular, and the risk of losing a significant portion or all of the principal amount.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The U.S. Federal Income Tax Consequences Of
An Investment In The Securities Are Uncertain</B> &mdash; There is no direct legal authority regarding the proper U.S. federal income
tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;). Consequently,
significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of
the securities as prepaid forward contracts, as described below under &ldquo;Tax Considerations.&rdquo; If the IRS were successful in
asserting an alternative treatment for the securities, the tax consequences of the ownership and disposition of the securities could be
materially and adversely affected. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, in 2007
the Treasury Department and the IRS released a notice requesting comments on various issues regarding the U.S. federal income tax treatment
of &ldquo;prepaid forward contracts&rdquo; and similar instruments. Any Treasury regulations or other guidance promulgated after consideration
of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive
effect. You should review carefully the sections of the accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income
Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S.
holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders,&rdquo; and consult your tax advisor regarding the U.S. federal tax consequences
of an investment in the securities (including possible alternative treatments and the issues presented by the 2007 notice), as well as
tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Are Subject To The Credit Risk
Of Barclays Bank PLC</B> &mdash; The securities are unsecured and unsubordinated debt obligations of the issuer, Barclays Bank PLC, and
are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the securities, including any repayment
of principal, is subject to the ability of Barclays Bank PLC to satisfy its obligations as they come due and is not guaranteed by any
third party. As a result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the securities
and, in the event Barclays Bank PLC were to default on its obligations, you might not receive any amount owed to you under the terms of
the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You May Lose Some Or All Of Your Investment
If Any U.K. Bail-In Power Is Exercised By The Relevant U.K. Resolution Authority &mdash; </B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority as set forth under &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement. Accordingly, any
U.K. Bail-in Power may be exercised in such a manner as to result in you and other holders and beneficial owners of the securities losing
all or a part of the value of your investment in the securities or receiving a different security from the securities, which may be worth
significantly less than the securities and which may have significantly fewer protections than those typically afforded to debt securities.
Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power without providing any advance notice to, or requiring
the consent of, the holders and beneficial owners of the securities. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution
authority with respect to the securities will not be a default or an Event of Default (as each term is defined in the senior debt securities
indenture) and the trustee will not be liable for any action that the trustee takes, or abstains from taking, in either case, in accordance
with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities. See &ldquo;Consent
to U.K. Bail-in Power&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating
to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail,
including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely
affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms
of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Underlying
Stocks</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>There Are Risks Associated With Single Equities
</B>&mdash; The price of each Underlying Stock can rise or fall sharply due to factors specific to that Underlying Stock and its issuer,
such as stock price volatility, earnings, financial conditions, corporate, industry and </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">regulatory developments,
management changes and decisions and other events, as well as general market factors, such as general stock market volatility and levels,
interest rates and economic and political conditions. We urge you to review financial and other information filed periodically with the
SEC by the issuer of each Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We Cannot Control Actions By An Underlying
Stock Issuer</B> &mdash; Actions by an Underlying Stock Issuer may have an adverse effect on the price of such Underlying Stock, the ending
price of such Underlying Stock, and the value of the securities. We are not affiliated with either Underlying Stock Issuer. No Underlying
Stock Issuer will be involved in the offering of the securities nor will either Underlying Stock Issuer have any obligations with respect
to the securities, including any obligation to take our interests or your interests into consideration for any reason. No Underlying Stock
Issuer will receive any of the proceeds of the offering of the securities nor will be responsible for, or will have participated in, the
determination of the timing of, prices for, or quantities of, the securities to be issued. No Underlying Stock Issuer will be involved
with the administration, marketing or trading of the securities nor will have any obligations with respect to any amounts payable on the
securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We And Our Affiliates Have No Affiliation
With Either Underlying Stock Issuer And Have Not Independently Verified Their Public Disclosure Of Information</B> &mdash; We, our affiliates
and WFS and its affiliates are not affiliated in any way with either Underlying Stock Issuer. This pricing supplement relates only to
the securities and does not relate to either Underlying Stock. The material provided in this pricing supplement concerning an Underlying
Stock Issuer is derived from publicly available documents without independent verification. Neither we nor either agent has participated
in the preparation of any of those documents or made any &ldquo;due diligence&rdquo; investigation or any inquiry of the Underlying Stock
Issuers. Furthermore, neither we nor either agent knows whether either Underlying Stock Issuer has disclosed all events occurring before
the date of this pricing supplement, including events that could affect the accuracy or completeness of the publicly available documents
referred to above. Subsequent disclosure of any event of this kind or the disclosure of or failure to disclose material future events
concerning an Underlying Stock Issuer could affect the value of the securities and any payments on the securities. You, as an investor
in the securities, should make your own investigation into each Underlying Stock Issuer.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Have Limited Anti-dilution Protection</B>
&mdash; The calculation agent will, in its sole discretion, adjust the adjustment factor of an Underlying Stock for certain events affecting
such Underlying Stock, such as stock splits and stock dividends, and certain other corporate actions involving the applicable Underlying
Stock Issuer, such as mergers. However, the calculation agent is not required to make an adjustment for every corporate event that can
affect an Underlying Stock. For example, the calculation agent is not required to make any adjustments to the adjustment factor of an
Underlying Stock if the applicable Underlying Stock Issuer or anyone else makes a partial tender or partial exchange offer for such Underlying
Stock. Consequently, this could affect the value of the securities and any payments on the securities. See &ldquo;General Terms of the
Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment Events&rdquo; in the accompanying product
supplement for a description of the general circumstances in which the calculation agent will make adjustments to the adjustment factor
of an Underlying Stock. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities May Become Linked To The Common
Stock Of A Company Other Than An Original Underlying Stock Issuer </B>&mdash; Following certain corporate events relating to an Underlying
Stock, such as a stock-for-stock merger where the applicable Underlying Stock Issuer is not the surviving entity, the shares of a successor
corporation to such Underlying Stock Issuer will be substituted for such Underlying Stock for all purposes of the securities. Following
certain other corporate events relating to an Underlying Stock in which holders of such Underlying Stock would receive all of their consideration
in cash and the surviving entity has no marketable securities outstanding or there is no surviving entity (including, but not limited
to, a leveraged buyout or other going private transaction involving such Underlying Stock Issuer, or a liquidation of such Underlying
Stock Issuer), the common stock of another company in the same industry group as such Underlying Stock Issuer will be substituted for
such Underlying Stock for all purposes of the securities. In any such event, the equity-linked nature of the securities would be significantly
altered. See &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment
Events&rdquo; in the accompanying product supplement for a description of the specific events that can lead to these adjustments and the
procedures for selecting a replacement stock. The occurrence of such events and the consequent adjustments may materially and adversely
affect the value of the securities and any payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Historical Performance Of The Underlying
Stocks Is Not An Indication Of Their Future Performance &mdash;</B> The historical performance of the Underlying Stocks should not be
taken as an indication of the future performance of the Underlying Stocks. It is impossible to predict whether the stock closing prices
of the Underlying Stocks will fall or rise during the term of the securities, in particular in the environment in the last several years,
which has been characterized by volatility across a wide range of asset classes. Past fluctuations and trends in the prices of the Underlying
Stocks are not necessarily indicative of fluctuations or trends that may occur in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to Conflicts
of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Potentially Inconsistent Research, Opinions
Or Recommendations By Barclays Capital Inc., WFS Or Their Respective Affiliates</B> &mdash; Barclays Capital Inc., WFS or their respective
affiliates may publish research from time to time on financial markets and other matters that may influence the value of the securities
or express opinions or provide recommendations that are inconsistent with purchasing or holding the securities. Any research, opinions
or recommendations expressed by Barclays Capital Inc., WFA or their respective affiliates may not be consistent with each other and may
be modified from time to time without notice. You should make your own independent investigation of each Underlying Stock and the merits
of investing in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We, Our Affiliates And Any Other Agent And/Or
Participating Dealer May Engage In Various Activities Or Make Determinations That Could Materially Affect Your Securities In Various Ways
And Create Conflicts Of Interest</B> &mdash; We, our affiliates, WFS and any dealer participating in the distribution of the securities
(a &ldquo;<U>participating dealer</U>&rdquo;) may play a variety of roles in connection with the issuance of the securities, as described
below. In performing these roles, our economic interests and the economic interests of our affiliates, WFS and any participating dealer
are potentially adverse to your interests as an investor in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In connection with
our normal business activities and in connection with hedging our obligations under the securities, we and our affiliates make markets
in and trade various financial instruments or products for our accounts and for the account of our clients and otherwise provide investment
banking and other financial services with respect to these financial instruments and products. These financial instruments and products
may include securities, derivative instruments or assets that may relate to the Underlying Stocks. In any such market making, trading
and hedging activity, investment banking and other financial services, we or our affiliates may take positions or take actions that are
inconsistent with, or adverse to, the investment objectives of the holders of the securities. We and our affiliates have no obligation
to take the needs of any buyer, seller or holder of the securities into account in conducting these activities. Such market making, trading
and hedging activity, investment banking and other financial services may negatively impact the value of the securities. Participating
dealers may also engage in such activities that may negatively impact the value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, the
role played by Barclays Capital Inc., as the agent for the securities, could present significant conflicts of interest with the role of
Barclays Bank PLC, as issuer of the securities. For example, Barclays Capital Inc. or its representatives may derive compensation or financial
benefit from the distribution of the securities and such compensation or financial benefit may serve as an incentive to sell the securities
instead of other investments. Furthermore, we and our affiliates establish the offering price of the securities for initial sale to the
public, and the offering price is not based upon any independent verification or valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Furthermore, if any
dealer participating in the distribution of the securities or any of its affiliates conducts hedging activities for us in connection with
the securities, that participating dealer or its affiliates will expect to realize a projected profit from such hedging activities, and
this projected profit will be in addition to any selling concession and/or any fee that the participating dealer realizes for the sale
of the securities to you. This additional projected profit may create a further incentive for the participating dealer to sell the securities
to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In addition to the activities described
above, Barclays Bank PLC will also act as the calculation agent for the securities. As calculation agent, we will determine any prices
of the Underlying Stocks and make any other determinations necessary to calculate any payments on the securities. In making these determinations,
we may be required to make discretionary judgments, including those described in the accompanying product supplement and under &ldquo;&mdash;Risks
Relating to the Underlying Stocks&rdquo; above. In making these discretionary judgments, our economic interests are potentially adverse
to your interests as an investor in the securities, and any of these determinations may adversely affect any payments on the securities.
Absent manifest error, all determinations of the calculation agent will be final and binding, without any liability on the part of the
calculation agent. You will not be entitled to any compensation from Barclays Bank PLC for any loss suffered as a result of any determinations
made by the calculation agent with respect to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Estimated
Value of the Securities and the Secondary Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Will Not Be Listed On Any Securities
Exchange And We Do Not Expect A Trading Market For The Securities To Develop</B> &mdash; The securities will not be listed on any securities
exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to make a secondary market for the securities but are
not required to do so, and may discontinue any such secondary market making at any time, without notice. Even if there is a secondary
market, it may not provide enough liquidity to allow you to trade or sell the securities easily. Because other dealers are not likely
to make a secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the
price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are willing to buy the securities. The securities
are not designed to be short-term trading instruments. Accordingly, you should be willing and able to hold your securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Value Of The Securities Prior To Maturity
Will Be Affected By Numerous Factors, Some Of Which Are Related In Complex Ways</B> &mdash; Structured notes, including the securities,
can be thought of as securities that combine a debt instrument with one or more options or other derivative instruments. As a result,
the factors that influence the values of debt instruments and options or other derivative instruments will also influence the terms and
features of the securities at issuance and their value in the secondary market. Accordingly, in addition to the prices of the Underlying
Stocks on any day, the value of the securities will be affected by a number of economic and market factors that may either offset or magnify
each other, including:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the expected volatility of the Underlying Stocks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">correlation (or lack of correlation) of the Underlying
Stocks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the time to maturity of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the market prices of, and dividend rates on,
the Underlying Stocks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">interest and yield rates in the market generally;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">supply and demand for the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a variety of economic, financial, political,
regulatory and judicial events; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our creditworthiness, including actual or anticipated
downgrades in our credit ratings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Lower Than The Original Offering Price Of Your Securities</B> &mdash; The estimated value of your securities on the pricing date is lower
than the original offering price of your securities. The difference between the original offering price of your securities and the estimated
value of the securities is a result of certain factors, such as any sales commissions, selling concessions, discounts, commissions or
fees to be allowed or paid to Barclays Capital Inc., another affiliate of ours, WFS or its affiliates or other non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the estimated cost
that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may incur in connection
with the securities.&#9;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Might
Be Lower If Such Estimated Value Were Based On The Levels At Which Our Debt Securities Trade In The Secondary Market</B> &mdash; The estimated
value of your securities on the pricing date is based on a number of variables, including our internal funding rates. Our internal funding
rates may vary from the levels at which our benchmark debt securities trade in the secondary market. As a result of this difference, the
estimated value referenced above might be lower if such estimated value were based on the levels at which our benchmark debt securities
trade in the secondary market.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of The Securities Is Based
On Our Internal Pricing Models, Which May Prove To Be Inaccurate And May Be Different From The Pricing Models Of Other Financial Institutions</B>
&mdash; The estimated value of your securities on the pricing date is based on our internal pricing models, which take into account a
number of variables and are based on a number of subjective assumptions, which may or may not materialize. These variables and assumptions
are not evaluated or verified on an independent basis. Further, our pricing models may be different from other financial institutions&rsquo;
pricing models and the methodologies used by us to estimate the value of the securities may not be consistent with those of other financial
institutions that may be purchasers or sellers of securities in the secondary market. As a result, the secondary market price of your
securities may be materially different from the estimated value of the securities determined by reference to our internal pricing models.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Not A Prediction Of The Prices At Which You May Sell Your Securities In The Secondary Market, If Any, And Such Secondary Market Prices,
If Any, Will Likely Be Lower Than The Original Offering Price Of Your Securities And May Be Lower Than The Estimated Value Of Your Securities</B>
&mdash; The estimated value of the securities will not be a prediction of the prices at which Barclays Capital Inc., other affiliates
of ours or third parties may be willing to purchase the securities from you in secondary market transactions (if they are willing to purchase,
which they are not obligated to do). The price at which you may be able to sell your securities in the secondary market at any time will
be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades,
and may be substantially less than our estimated value of the securities. Further, as secondary market prices of your securities take
into account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs related
to the securities such as fees, commissions, discounts, and the costs of hedging our obligations under the securities, secondary market
prices of your securities will likely be lower than the original offering price of your securities. As a result, the price at which Barclays
Capital Inc., other affiliates of ours or third parties may be willing to purchase the securities from you in secondary market transactions,
if any, will likely be lower than the price you paid for your securities, and any sale prior to the stated maturity date could result
in a substantial loss to you.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Temporary Price At Which We May Initially
Buy The Securities In The Secondary Market And The Value We May Initially Use For Customer Account Statements, If We Provide Any Customer
Account Statements At All, May Not Be Indicative Of Future Prices Of Your Securities</B> &mdash; Assuming that all relevant factors remain
constant after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market
(if Barclays Capital Inc. makes a market in the securities, which it is not obligated to do) and the value that we may initially use for
customer account statements, if we provide any customer account statements at all, may exceed our estimated value of the securities on
the pricing date, as well as the secondary market value of the securities, for a temporary period after the initial issue date of the
securities. The price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market and the value that
we may initially use for customer account statements may not be indicative of future prices of your securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Examples and Returns</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples
below illustrate the maturity payment amount for a $1,000 principal amount security on a hypothetical offering of securities under various
scenarios, with the assumptions set forth in the table below. Terms used for purposes of these hypothetical examples do not represent
the actual starting price, threshold price or ending price of either Underlying Stock applicable to the securities. The actual maturity
payment amount and resulting pre-tax total rate of return will depend on the actual terms of the securities. You should not take these
examples as an indication or assurance of the expected performance of the securities. These examples are for purposes of illustration
only. The values used in the examples may have been rounded for ease of analysis. The examples below do not take into account any tax
consequences from investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Georgia, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1pt 4pt; width: 36%; border: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Contingent Fixed Return: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 64%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">14.70% of the principal amount or $147.00 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Starting Price: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">For each Underlying Stock, $100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Threshold Price: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">For each Underlying Stock, $60.00 (60% of its hypothetical starting price)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The hypothetical starting price of $100.00 for
each Underlying Stock has been chosen for illustrative purposes only and does not represent the actual starting price of either Underlying
Stock. For each Underlying Stock, the actual starting price and threshold price are set forth under &ldquo;Terms of the Securities&rdquo;
above, and the actual ending price will be the stock closing price of that Underlying Stock on the calculation day. For historical closing
prices of the Underlying Stocks, see the historical information set forth under the sections titled &ldquo;The Common Stock of Advanced
Micro Devices, Inc.&rdquo; and &ldquo;The Common Stock of NVIDIA Corporation&rdquo; below. We cannot predict the stock closing price of
the Underlying Stocks on any day during the term of the securities, including on the calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 350px; width: 550px"></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
ending price of the lowest performing Underlying Stock</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
stock return of the lowest performing Underlying Stock</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical maturity payment amount per security</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical pre-tax total rate of return</B></FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$175.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$140.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$130.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$120.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$114.70</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$110.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$105.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$95.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-5.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$90.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$75.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-25.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$60.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-40.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,147.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$59.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-41.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$590.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-41.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$50.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$500.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-75.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$250.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-75.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-100.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Hypothetical Examples</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1. Maturity payment amount is greater
than the principal amount and reflects a return that is equal to the contingent fixed return, which is greater than the percentage increase
in the stock closing price of the lowest performing Underlying Stock from its hypothetical starting price to its hypothetical ending price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Georgia, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 64%; border: Black 1pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMD Stock</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NVDA Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting price:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending price:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$110.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$190.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold price: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical stock return: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">90.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 1</U>: Determine which Underlying Stock
is the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this example, the AMD Stock has the lowest
stock return and is, therefore, the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 2</U>: Determine the maturity payment
amount based on the ending price of the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price of the lowest
performing Underlying Stock is greater than or equal to its hypothetical threshold price, the maturity payment amount per security would
be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">$1,000 +
the contingent fixed return of $147.00;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">= $1,147.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,147.00 per security, which is the maximum maturity payment amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. Maturity payment amount is greater
than the principal amount and reflects a return equal to the contingent fixed return, which is less than the percentage increase in the
stock closing price of the lowest performing Underlying Stock from its hypothetical starting price to its hypothetical ending price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Georgia, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 64%; border: Black 1pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMD Stock</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NVDA Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting price:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending price:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$150.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$130.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold price: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical stock return: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">50.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">30.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 1</U>: Determine which Underlying Stock
is the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this example, the NVDA Stock has the lowest
stock return and is, therefore, the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 2</U>: Determine the maturity payment
amount based on the ending price of the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price of the lowest
performing Underlying Stock is greater than or equal to its hypothetical threshold price, the maturity payment amount per security would
be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + the contingent fixed return of $147.00;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">= $1,147.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,147.00 per security, which is the maximum maturity payment amount. Even though the lowest performing Underlying Stock increased by
30% from its hypothetical starting price to its hypothetical ending price in this example, your return is limited to the contingent fixed
return of 14.70%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3. Maturity payment amount is greater
than the principal amount and reflects a return equal to the contingent fixed return, even though the ending price of the lowest performing
Underlying Stock is less than its starting price but is greater than its threshold price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Georgia, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 64%; border: Black 1pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMD Stock</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NVDA Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting price:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending price:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$95.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$90.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold price: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical stock return: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">-5.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">-10.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 1</U>: Determine which Underlying Stock
is the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this example, the NVDA Stock has the lowest
stock return and is, therefore, the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 2</U>: Determine the maturity payment
amount based on the ending price of the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price of the lowest
performing Underlying Stock is greater than or equal to its hypothetical threshold price, the maturity payment amount per security would
be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + the contingent fixed return of $147.00;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,147.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,147.00 per security, which is the maximum maturity payment amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 4. Maturity payment amount is less
than the principal amount:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Georgia, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 64%; border: Black 1pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMD Stock</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NVDA Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting price:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending price:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$50.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$120.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold price: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Hypothetical stock return: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">-50.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">20.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 1</U>: Determine which Underlying Stock
is the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this example, the AMD Stock has the lowest
stock return and is, therefore, the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 2</U>: Determine the maturity payment
amount based on the ending price of the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price of the lowest
performing Underlying Stock is less than its hypothetical starting price by more than 40%, you would lose a portion of the principal amount
of your securities and receive the maturity payment amount equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 &times; stock return of the lowest
performing Underlying Stock)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 + ($1,000 &times; -50.00%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $500.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$500.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This example illustrates that you will be fully
exposed to a decrease in the lowest performing Underlying Stock if the ending price of the lowest performing Underlying Stock is less
than its threshold price, even if the ending price of the other Underlying Stock has appreciated or has not declined below its threshold
price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Information
about the Underlying Stocks</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We urge you to read the following section in the
accompanying prospectus supplement: &ldquo;Reference Assets &mdash; Equity Securities &mdash; Reference Asset Issuer and Reference Asset
Information.&rdquo; Companies with securities registered under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
are required to file financial and other information specified by the SEC periodically. Such information can be reviewed electronically
through a website maintained by the SEC at http://www.sec.gov. Information filed with the SEC by the issuer of each Underlying Stock can
be located by reference to its SEC file number provided below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Included below is a brief description of the issuer
of each Underlying Stock. This information has been obtained from publicly available sources. Information from outside sources is not
incorporated by reference in, and should not be considered part of, this pricing supplement or any accompanying prospectus or prospectus
supplement. We have not independently verified the accuracy or completeness of the information contained in outside sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
Common Stock of Advanced Micro Devices, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to publicly available information, Advanced
Micro Devices, Inc. is a semiconductor company whose products include Artificial Intelligence (AI) accelerators, microprocessors (CPUs)
for servers and graphics processing units (GPUs), as standalone devices or as incorporated into accelerated processing units (APUs), chipsets,
data center and professional GPUs, embedded processors, semi-custom System-on-Chip (SOC) products, microprocessor and SoC development
services and technology, data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), System on Modules (SOMs), Smart Network
Interface Cards (SmartNICs) and Adaptive SoC products and that, from time to time, may also sell or license portions of its intellectual
property portfolio. Information filed by Advanced Micro Devices, Inc. with the SEC under the Exchange Act can be located by reference
to its SEC file number: 001-07882. The AMD Stock is listed on The Nasdaq Stock Market under the ticker symbol &ldquo;AMD.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing prices of the AMD Stock
displayed in the graph below from Bloomberg Professional<SUP>&reg;</SUP> service (&ldquo;Bloomberg&rdquo;) without independent verification.
The historical performance of the AMD Stock should not be taken as an indication of the future performance of the AMD Stock. Future performance
of the AMD Stock may differ significantly from historical performance, and no assurance can be given as to the closing prices of the AMD
Stock during the term of the securities, including on the calculation day. We cannot give you assurance that the performance of the AMD
Stock will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing prices
of the AMD Stock for the period from January 1, 2020 to October 17, 2025. The closing price on October 17, 2025 was $233.08. <I>The closing
prices below may reflect adjustments in response to certain corporate actions, such as stock splits, public offerings, mergers and acquisitions,
spin-offs, extraordinary dividends, delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 322px; width: 614px"></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The dotted line indicates the threshold price
of 60% of the starting price of the AMD Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
Common Stock of NVIDIA Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to publicly available information, NVIDIA
Corporation is a full-stack computing infrastructure company with data-center-scale offerings whose full-stack includes the CUDA programming
model that runs on all of its graphics processing units (GPUs), as well as domain-specific software libraries, software development kits
and Application Programming Interfaces. Information filed by NVIDIA Corporation with the SEC under the Exchange Act can be located by
reference to its SEC file number: 000-23985. The NVDA Stock is listed on The Nasdaq Stock Market under the ticker symbol &ldquo;NVDA.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing prices of the NVDA Stock
displayed in the graph below from Bloomberg without independent verification. The historical performance of the NVDA Stock should not
be taken as an indication of the future performance of the NVDA Stock. Future performance of the NVDA Stock may differ significantly from
historical performance, and no assurance can be given as to the closing prices of the NVDA Stock during the term of the securities, including
on the calculation day. We cannot give you assurance that the performance of the NVDA Stock will not result in a loss on your initial
investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing prices
of the NVDA Stock for the period from January 1, 2020 to October 17, 2025. The closing price on October 17, 2025 was $183.22. <I>The closing
prices below may reflect adjustments in response to certain corporate actions, such as stock splits, public offerings, mergers and acquisitions,
spin-offs, extraordinary dividends, delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><IMG SRC="image_004.jpg" ALT="" STYLE="height: 322px; width: 614px"></B></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The dotted line indicates the threshold price
of 60% of the starting price of the NVDA Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Tax
Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should review carefully the sections in the
accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes
Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders.&rdquo;
The following discussion, when read in combination with those sections, constitutes the full opinion of our special tax counsel, Davis
Polk &amp; Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on current market conditions, in the opinion
of our special tax counsel, it is reasonable to treat the securities for U.S. federal income tax purposes as prepaid forward contracts
with respect to the Underlying Stocks. Assuming this treatment is respected, if you are a U.S. holder, upon a sale or exchange of the
securities (including redemption at maturity), you should recognize capital gain or loss equal to the difference between the amount realized
on the sale or exchange and your tax basis in the securities, which should equal the amount you paid to acquire the securities. This gain
or loss on your securities should be treated as long-term capital gain or loss if you hold your securities for more than a year, whether
or not you are an initial purchaser of the securities at the original issue price. The deductibility of capital losses is subject to limitations.
However, the IRS or a court may not respect this treatment, in which case the timing and character of any income or loss on the securities
could be materially and adversely affected. In addition, in 2007 the U.S. Treasury Department and the IRS released a notice requesting
comments on the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar instruments. The notice focuses
in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for
comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of
factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including
any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should
be subject to the &ldquo;constructive ownership&rdquo; regime, which very generally can operate to recharacterize certain long-term capital
gain as ordinary income and impose a notional interest charge. While the notice requests comments on appropriate transition rules and
effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely
affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should consult your tax advisor
regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the
issues presented by this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Treasury regulations under Section 871(m) generally
impose a withholding tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent
IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo;
with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying
Security&rdquo;). Based on our representation that the securities do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations,
our special tax counsel believes that these regulations should not apply to the securities with regard to non-U.S. holders, and we have
determined to treat the securities as not being subject to Section 871(m). Our determination is not binding on the IRS, and the IRS may
disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an Underlying Security. You should consult your tax advisor regarding the potential
application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-U.S. holders should also discuss with their
tax advisors the estate tax consequences of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due October 29, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Validity
of the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP,
as special United States products counsel to Barclays Bank PLC, when the securities offered by this pricing supplement have been issued
by Barclays Bank PLC pursuant to the indenture, the trustee has made, in accordance with instructions from Barclays Bank PLC, appropriate
entries or notations in its records relating to the master global note that represents such securities (the &ldquo;master note&rdquo;),
and such securities have been delivered against payment as contemplated herein, such securities will be valid and binding obligations
of Barclays Bank PLC, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting
creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation,
concepts of good faith, fair dealing and the lack of bad faith) and possible judicial or regulatory actions or application giving effect
to governmental actions or foreign laws affecting creditors&rsquo; rights, <I>provided </I>that such counsel expresses no opinion as to
(i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above
or (ii) the validity, legally binding effect or enforceability of any provision that permits holders to collect any portion of the stated
principal amount upon acceleration of the securities to the extent determined to constitute unearned interest. This opinion is given as
of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by English law,
Davis Polk &amp; Wardwell LLP has relied, with Barclays Bank PLC&rsquo;s permission, on the opinion of Davis Polk &amp; Wardwell London
LLP, dated as of May 15, 2025, filed as an exhibit to the Registration Statement on Form F-3ASR by Barclays Bank PLC on May 15, 2025,
and this opinion is subject to the same assumptions, qualifications and limitations as set forth in such opinion of Davis Polk &amp; Wardwell
London LLP. In addition, this opinion is subject to customary assumptions about the trustee&rsquo;s authorization, execution and delivery
of the indenture and its authentication of the master note and the validity, binding nature and enforceability of the indenture with respect
to the trustee, all as stated in the opinion of Davis Polk &amp; Wardwell LLP, dated May 15, 2025, which has been filed as an exhibit
to the Registration Statement referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236099_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 4c50ac9aec6e5e24c3293f98d0e477d1 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0000312070</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-287303</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-21</xbrli:startDate>
          <xbrli:endDate>2025-10-21</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-21</xbrli:startDate>
          <xbrli:endDate>2025-10-21</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_010">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_011">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_013">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">928</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">928,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-223">128.16</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-224">928,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-225">128.16</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-226">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-227">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-228">128.16</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-230">928,000</ix:nonFraction>.
<ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-231">The prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  J +,# 2(  A$! Q$!_\0
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C'(1W90:L447!Q3W1''#'$H6-0JCH%&!4E%% TK!1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %4 R<# 2(  A$! Q$!_\0
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M #X:I_X#C_XJN,HK7V2,?:L[/_A8FE_\^&J?^ X_^*H_X6)I?_/AJG_@./\
MXJN,HH]D@]JSL_\ A8FE_P#/AJG_ (#C_P"*H_X6)I?_ #X:I_X#C_XJN,HH
M]D@]JSL_^%B:7_SX:I_X#C_XJC_A8FE_\^&J?^ X_P#BJXRBCV2#VK.S_P"%
MB:7_ ,^&J?\ @./_ (JC_A8FE_\ /AJG_@./_BJXRBCV2#VK.S_X6)I?_/AJ
MG_@./_BJ/^%B:7_SX:I_X#C_ .*KC**/9(/:L[/_ (6)I?\ SX:I_P" X_\
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M/?:'8(24S\I(P2/I5:X_X^-+_P"PK8?^E45#^$%\1[31117*=84444 %%%%
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M3X(;V[^UW**!)<>6(_,/KM' ^E6:AVOH)!1112&%%%% !1110 4444 %%%%
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M@K2I-6 ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&)CD\S)53SM/'(ZXZ8K)HC>VHIVOH%,D\OSK0/\ >-Y;B(^DIF3RR?8/M/\
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M%Y-->QSH4F:X89<$8/"@ <=E %9H\)V[:<ME<:CJ%PL+(UL\DBAK<J05*[5
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M8W&S(9CEL;57@GFM6BBDW< HHHI %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !3-%_Y'"[_Z\(O_ $8]/J/1"/\ A,+T#J+"'/MF23'\C^5:4_B$
MSJZ***ZA!1UHHH Y^X\$>&KB5I#I,$3L=S&W+0[CZG81DU%_P@/AO_GRF_\
M V?_ .+KI:*=V*R.:_X0'PW_ ,^4W_@;/_\ %T?\(#X;_P"?*;_P-G_^+KI:
M*+L+(YK_ (0'PW_SY3?^!L__ ,71_P (#X;_ .?*;_P-G_\ BZZ6BB["R.:_
MX0'PW_SY3?\ @;/_ /%UC^(_"VCZ-IT=Q8VSI*TH0EYY)!@@GHS$=AS7>US?
MC7_D"1_]=U_]!:J@WS(F:7*R*#P+X=FMXY7LY2SH&)%W,!DCV>I/^$!\-_\
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MME&Q_,K6U10!S_\ P@G@_P#Z%30__!=%_P#$T?\ "">#_P#H5-#_ /!=%_\
M$UT%% '/_P#"">#_ /H5-#_\%T7_ ,31_P ()X/_ .A4T/\ \%T7_P 37044
M <__ ,()X/\ ^A4T/_P71?\ Q-'_  @G@_\ Z%30_P#P71?_ !-=!10!S_\
MP@G@_P#Z%30__!=%_P#$T?\ "">#_P#H5-#_ /!=%_\ $UT%% '/_P#"">#_
M /H5-#_\%T7_ ,31_P ()X/_ .A4T/\ \%T7_P 37044 <__ ,()X/\ ^A4T
M/_P71?\ Q-'_  @G@_\ Z%30_P#P71?_ !-=!10!S_\ P@G@_P#Z%30__!=%
M_P#$T?\ "">#_P#H5-#_ /!=%_\ $UT%% '/_P#"">#_ /H5-#_\%T7_ ,31
M_P ()X/_ .A4T/\ \%T7_P 37044 <__ ,()X/\ ^A4T/_P71?\ Q-'_  @G
M@_\ Z%30_P#P71?_ !-=!10!S_\ P@G@_P#Z%30__!=%_P#$T?\ "">#_P#H
M5-#_ /!=%_\ $UT%% '/_P#"">#_ /H5-#_\%T7_ ,31_P ()X/_ .A4T/\
M\%T7_P 37044 <__ ,()X/\ ^A4T/_P71?\ Q-'_  @G@_\ Z%30_P#P71?_
M !-=!10!S_\ P@G@_P#Z%30__!=%_P#$T?\ "">#_P#H5-#_ /!=%_\ $UT%
M% '/_P#"">#_ /H5-#_\%T7_ ,31_P ()X/_ .A4T/\ \%T7_P 37044 <__
M ,()X/\ ^A4T/_P71?\ Q-'_  @G@_\ Z%30_P#P71?_ !-=!10!S_\ P@G@
M_P#Z%30__!=%_P#$T?\ "">#_P#H5-#_ /!=%_\ $UT%% '/_P#"">#_ /H5
M-#_\%T7_ ,31_P ()X/_ .A4T/\ \%T7_P 37044 <__ ,()X/\ ^A4T/_P7
M1?\ Q-'_  @G@_\ Z%30_P#P71?_ !-=!10!S_\ P@G@_P#Z%30__!=%_P#$
MT?\ "">#_P#H5-#_ /!=%_\ $UT%% '/_P#"">#_ /H5-#_\%T7_ ,31_P (
M)X/_ .A4T/\ \%T7_P 37044 <__ ,()X/\ ^A4T/_P71?\ Q-'_  @G@_\
MZ%30_P#P71?_ !-=!10!S_\ P@G@_P#Z%30__!=%_P#$T?\ "">#_P#H5-#_
M /!=%_\ $UT%% '/_P#"">#_ /H5-#_\%T7_ ,31_P ()X/_ .A4T/\ \%T7
M_P 37044 <__ ,()X/\ ^A4T/_P71?\ Q-'_  @G@_\ Z%30_P#P71?_ !-=
M!10!S_\ P@G@_P#Z%30__!=%_P#$T?\ "">#_P#H5-#_ /!=%_\ $UT%% '/
M_P#"">#_ /H5-#_\%T7_ ,31_P ()X/_ .A4T/\ \%T7_P 37044 <__ ,()
MX/\ ^A4T/_P71?\ Q-'_  @G@_\ Z%30_P#P71?_ !-=!10!S_\ P@G@_P#Z
M%30__!=%_P#$T?\ "">#_P#H5-#_ /!=%_\ $UT%% '/_P#"">#_ /H5-#_\
M%T7_ ,31_P ()X/_ .A4T/\ \%T7_P 37044 <__ ,()X/\ ^A4T/_P71?\
MQ-'_  @G@_\ Z%30_P#P71?_ !-=!10!S_\ P@G@_P#Z%30__!=%_P#$T?\
M"">#_P#H5-#_ /!=%_\ $UT%% '/_P#"">#_ /H5-#_\%T7_ ,31_P ()X/_
M .A4T/\ \%T7_P 37044 8MOX/\ #%I)YEMX<TB%_P"]'8Q*?S"UL(B1H$C5
M511@*HP!3J* "BBB@ HHHH **** "BBB@ HHHH **** "N=\:?\ (#3_ *[K
M_(UT5<[XT_Y :_\ 79?Y&JA\2)G\+-C3?^059_\ 7!/_ $$5:JKIG_(*L_\
MK@G_ *"*M4GN-;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"QH_\)?H7_/^/^_3_P"%'_"7Z%_S_C_OT_\ A6=11SA8T?\ A+]"_P"?\?\
M?I_\*/\ A+]"_P"?\?\ ?I_\*SJ*.<+&C_PE^A?\_P"/^_3_ .%'_"7Z%_S_
M (_[]/\ X5G44<X6-'_A+]"_Y_Q_WZ?_  H_X2_0O^?\?]^G_P *SJ*.<+&C
M_P )?H7_ #_C_OT_^%'_  E^A?\ /^/^_3_X5G44<X6-'_A+]"_Y_P ?]^G_
M ,*/^$OT+_G_ !_WZ?\ PK.HHYPL:/\ PE^A?\_X_P"_3_X4?\)?H7_/^/\
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MT+_G_'_?I_\ "C_A+]"_Y_Q_WZ?_  K.HHYPL:/_  E^A?\ /^/^_3_X4?\
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MRSL3EF8]R222?>GZLYNO&K*<[+"Q4)SQOE=BW'J!$G/^T<=ZFK.3U*04445
MPHHHH **** "BJ+ZUI45PEN^IV:3/(8EC:=0S.,94#.<C(X]Q4MEJ%EJ4!GL
M+RWNH0Q4R02*Z@CJ,@]: +-%%% !11445S!,\J0S1R/"VR14<$HV <'T."#S
MZT 2T444 %%%% !1110 4444 %%1W%Q!:0-/<31PPIRTDC!57ZDU)0 4444
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M7_HQZZRMH[$L****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*YOYHY)M*ED:*-(Q&P$J+QE=P5L!NN?0@<5W=[IMCJ4:QW]E;W4:-N59XE<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH -"_Y&^\_P"O"+_T8]=97)Z%_P C?>?]>$7_ *,>NLK6.Q+"BBBJ$%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% ''7'_(TZM](?\ T"I:BN/^
M1IU;Z0_^@5+6,MRD%%%8VK^(5T?4;"R?3;VX:^?RX9(/+V[\$D'<X(X!/3'X
M\4NMA^9LT457N;ZWLY+:.>38]S+Y40VD[FP6QQTX4]?2@"Q161HFL3:I-J4%
MQ:1V\MC=&W(CF,@?Y%8-DJN.&Z8J]:S74LUTMQ:>1'')MA?S0WFK@'=@?=Y)
M&#Z4[ 6:***0!1110 4444 %%%% !1163JNHZA81WDMOID<T-O;><LDESY8D
M8$[DP%8C"C.<8.<>]%[#2N:U%<]HGB.?5=3-I+81VZM8PWL;K.7RLF>"-HP0
M0>YS5JQUB:Y\1:EI,UHD7V2.*6.5)B_F*Y8#(VC:1M/&35.+3L2FFK_UJ:]%
M%%2,**** "BBB@ HHK U/Q,MI:V]W901W=NU\MC,6D:,QL9!&2 5.[#>XZ<&
MFE=V0>9OT444@"BBB@ HI&8(I8G  R36)IGBNPU)96"3VL:0+<J]PJJLD+9Q
M(I!/!P>#@^U &Y13(I%FB21 VU@"-RE3CW!Y'XT^@ HHK'U_6+C1(K.:.SCN
M(9KJ*WE+3%&CWN%# ;3NY/3(H2N[ ;%%%% !112'(!(&3CI0 M%8%KKM^=<L
M=,OM*CM6NK5Y\BZ\QHV0J"I 4 _>'(-6&UB>/Q7%HSVB"&:U>XCN!,2?E905
M*;>/O#G<:=F!KT44V0N(V,:JS@':&; )]S@X_*D ZBN3T_QA=7<FD"72HHDO
M[J>T<K=%C%)%OZ#8-P/EGG(Z]*ZRFTT 45#=W,5E9SW4Q*Q0QM(Y'8 9/\JH
M6FKN=%DU74H(K.V$?GC9*TI$6W=EAM&&QU W?4T@-6BL8:W)_P )/!I/V6/R
M+BT:ZBN1,=QVE004*\??'.3]*V:=K %%%%( HJMYUR-2$ M/]$\HN;GS!P^<
M;-O7ISFK- !15:]FNK>%&M+3[5(9$5D\P)M4D!FR?09..^*LT %%1S&58)#
MB/*%)1';:I/8$@' ]\&J'A_5FUO1+?4'MQ;O+N#1"3>%*L5ZX&>GI0!IZ%_R
M-]Y_UX1?^C'KK*Y/0O\ D;[S_KPB_P#1CUUE:QV)844450@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH XZX_Y&G5OI#_ .@5+45Q_P C3JWTA_\
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MK:U,7V6_TN66&1MQ&T.!F)P  ),XP1U[:+:3JDOBMIKIO*NEO4F@FBTR21S
M,?NA<;PBKC<"I'7)^8D5W&KZE%H^ESWTRLR1 85>K$D #\20*FLWNWM5:]@A
MAG.=R0S&11Z88JI/Y52D]P:5K&?&]EXKT*YAN+.9;>5I()8+J,*P*DC..>XR
M#]#7$)H%W<>'TF&FQK=Z<\>GDVZ*'GMXY?WI4C!^9>-O^\.]>B?V?;BP-D@D
MCA((/ERNC\G).\$-DGG.<U+;V\5I;I! FR-!A5'^>:E.ST_K^OU&_P"OZ^[[
MCS>YT%K@W5YIFD2PZ7!>6=Q:VYMC$R%'S,\<3 ,N5P,  M@X!SSO^#HHTOO$
M4:Z=<6MO/?">)9K1X5=&C0$@, .H;(ZCO7744^;2W]=/\A6/-8_#^I:,UU_9
MNGL(=*OFFM8$&U;N*;_6*1CG:IP/I[4X:3!H&KZG:V6GWPA;13&3!:3/$TY)
MR$PI4$C!PO\ /->D45+=U;^MK#ZW_K>YP?A&61O$$!:QU"%5T6WMR\]E-$HD
M0MN7+*!GD?7M5;7X-0NO$NLK9VE\8VBLA(5@D59HTD8RHKX 8[6' //('>O1
M:K7DUU"(?LMI]H+RJD@\P)Y:'J_/7'IWJW*\K_UO<25E;^M$>?S::CQ:G]EL
MKZRT.>2 6]NFFNZB10Q=FMB WEGY01@9//O5*;1=1N+:UAN;*WLM/:"2.V2'
M29K@02F1CYJQJP:%F!4@MG;@CY>_HTFIF6UGDTR#[;-!/Y#Q;_*PP(#<L.P.
M??%:%*XSCO%MJ9/"NEQW5I=7EQ%=6KDQVK22*592[83=M^4-G![XR<USM_86
M]L-9-EHE\CPZI;R6/E:;-A%&SS&BPF #M?)'7WR,^IT4U*SO_73_ "#I;^NO
M^9YO?Z;=SW.HDZ?=R:Y-?I+IU\(6Q%!E<?O,8C &X%"03SP<U';Z$9X?$TNE
MZ=/9ZHEW*]G+):R0@QNJ!]F0H;=M?OUP>.#7HEE?6VH6_P!HM9/,BWNF[:1\
MRL58<^X(JQ2O96_KI_7G<.M_Z_K\CD?!>G-:/?2+^[M)UCQ;+I;V,<;@$-A)
M&))(QD@8..IYKF;C1X-+T>ZLDT*X2Y;6TE;[)ISMNMQ/O7YHU(*A >,\=, U
MZI5>2^MHK^&R>3%S,CR1IM/S*N-QSTXW#\Z:EK?^M-16TM_78X%0T2ZU81:#
M)-IIU%/*BNM,D>"&(QC<Z1%1O&\'A/7/3FJEKIZF/P_:W^E7LOV75+E&WZ?*
M5CMR) HR%($9W1\9QCV4X]1JM?S7-O922V=I]JG4?)#Y@CW<_P!X\"A2M^ V
M<_X.GDAT.^62UOHTM[N<PQ36TB-Y.XE BL 2-N  .G2N>@U.>\\=VUP3J$=Y
M<Z;<)'%-8SQI;DM'L&&0=/XGZ9[]!7H4-[;SW5Q:QOF:WV^:F#\NX9'/0\>E
M(^GVKZE%J#19NHHFA23<>$8@D8Z=5';M2OKKV_2P>G]:W.#TG3G6;05M=*N[
M75X9 =6N9+=D$J["'#RD8ERV,8+8]L58OO#[Z>!>V-I<6D/VA$*0@W,L<0R0
MX0[QP<;8P"%R3C/W>]HH<KB2.?T36;METZPU6UN4O[BW>8RF$*F%;&&Y^5R"
M#MQZUSWBJ&ZEUHW$6CM'-:7%L\-W;V#2SRQ;U\PB5?N@ L-G4_2N\^S1?:OM
M.S]]L\L,2>%SG '0>_K@>@J6B]FF%M+'ETD$5JEY>6.CZC#=+KL<D3Q:=.KB
M LAD*X3.PA7R!P>_44W5-.*M//>Z/>76L1ZQ'<I=I923$6HE4@(X4X 3@H.>
MIQWKU.BFI6MY?\#_ ""W]??_ )G$>.(=-?5?#-S?Z?\ :HS=NCJ+4S.R&%SM
MV %B,X)&.W2LR#3+I/L;ZEIMS+X:6YN3'IYMVE:.,[?)W0@%B =^!@[<C@8X
M[C4-"L-4O+2ZNTG::T;? 8[F2,(WKA6 /''/8D5I4D[*P/4\IN-(N_[/@CN=
M.N;B5/.-K8WEB]S"8FD8HF]>89 H'S$X4$ ^VF;!7\527+:;<S*[R^>\MC*D
M]LOELI,5PG#H>@09;YLBO0Z*.89Y9IUDC6?AU]7T6_N;2WL[J&XCFT^61@[.
MA7<A7<<XSG!]?>I]/TB>YU'2M-UNQNY89--NH9#);NZ1*\JM$C28*[@J^O!
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 445!>7<-A9RW4Y(BB7<<#)
M/L!W)Z =S0!-X:0R^*M8N-^8XK:VMPN/NOF1V_1H_P#)KK:Q/"NFS:?HV^[0
M+>W<K75PH_A9NB_\!4*O_ :VZV6Q 4444P"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@!" RD$ @\$'O7"WFG2^$FQ!#)-H.25\M2SV/^R5')B]"/
MNC@\<CNZ*35P./@GAN(4F@E26)QE'1@58>H(ZU)5N\\'Z=/+)/9/<:7<R$EI
M;)@H8GN8V!0GW*Y]ZIR>&==7 MM?L\>MSIID/_CLJ#]*CE95Q:*C_P"$;\3_
M /0P:1_X)Y?_ ))H_P"$;\3_ /0P:1_X)Y?_ ))I<K"Y)14?_"-^)_\ H8-(
M_P#!/+_\DT?\(WXG_P"A@TC_ ,$\O_R31RL+DE%1_P#"-^)_^A@TC_P3R_\
MR31_PC?B?_H8-(_\$\O_ ,DT<K"Y)14?_"-^)_\ H8-(_P#!/+_\DT?\(WXG
M_P"A@TC_ ,$\O_R31RL+DE%1_P#"-^)_^A@TC_P3R_\ R31_PC?B?_H8-(_\
M$\O_ ,DT<K"Y)14?_"-^)_\ H8-(_P#!/+_\DT?\(WXG_P"A@TC_ ,$\O_R3
M1RL+DE%1_P#"-^)_^A@TC_P3R_\ R31_PC?B?_H8-(_\$\O_ ,DT<K"Y)14?
M_"-^)_\ H8-(_P#!/+_\DT?\(WXG_P"A@TC_ ,$\O_R31RL+DE%1_P#"-^)_
M^A@TC_P3R_\ R31_PC?B?_H8-(_\$\O_ ,DT<K"Y)14?_"-^)_\ H8-(_P#!
M/+_\DT?\(WXG_P"A@TC_ ,$\O_R31RL+DE%1_P#"-^)_^A@TC_P3R_\ R31_
MPC?B?_H8-(_\$\O_ ,DT<K"Y)14?_"-^)_\ H8-(_P#!/+_\DT?\(WXG_P"A
M@TC_ ,$\O_R31RL+DE%1_P#"-^)_^A@TC_P3R_\ R31_PC?B?_H8-(_\$\O_
M ,DT<K"Y)14?_"-^)_\ H8-(_P#!/+_\DT?\(WXG_P"A@TC_ ,$\O_R31RL+
MDE%1_P#"-^)_^A@TC_P3R_\ R31_PC?B?_H8-(_\$\O_ ,DT<K"Y)14?_"-^
M)_\ H8-(_P#!/+_\DT?\(WXG_P"A@TC_ ,$\O_R31RL+DE%1_P#"-^)_^A@T
MC_P3R_\ R31_PC?B?_H8-(_\$\O_ ,DT<K"Y)14?_"-^)_\ H8-(_P#!/+_\
MDT?\(WXG_P"A@TC_ ,$\O_R31RL+DE%1_P#"-^)_^A@TC_P3R_\ R31_PC?B
M?_H8-(_\$\O_ ,DT<K"Y)14?_"-^)_\ H8-(_P#!/+_\DT?\(WXG_P"A@TC_
M ,$\O_R31RL+DE%1_P#"-^)_^A@TC_P3R_\ R31_PC?B?_H8-(_\$\O_ ,DT
M<K"Y)14?_"-^)_\ H8-(_P#!/+_\DT?\(WXG_P"A@TC_ ,$\O_R31RL+DE%1
M_P#"-^)_^A@TC_P3R_\ R31_PC?B?_H8-(_\$\O_ ,DT<K"Y)14?_"-^)_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
D% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %> B8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "O+-2U[5[0W>HP7TWDRRWL,3E]P.S@#RND>S:QW=\<_>
MKU.JBZ5IZW4MTMC;"XF!6241+N<'J"<<YP* .-NEU7S=7T[3[R[EMK*6"3>U
MWB0*T3%AYC'. WEN<GH2.^*O>'?$5Q<:K]BOHY6FF 42;@%#+&KXV=1E6#9]
M3CM72V^F6%I:-:6UG;PV[9W1)& ISUR.]/%E:K>M>K;0BZ9-AF"#>5],]<4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?5YA\:Y=77PND4%K;/I33P&YG>4B5'\Y=H5>A!XS7I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 453O\ 4[73E7SW)D<XCBC&YW/H%'6J7V;4
M-6W?;6:SM#TMXF_>./\ ;8=/H/SH EN=97SWM-/B-Y=K]Y4.$C_WVZ#Z=:;#
MH[3RI<ZM*+J9>5B Q#&?9>Y]S6C;VT%I"L-O$D4:]%08%2T '2BBB@ HHHH
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M%W*+[3%2 QSR0(LV9BL9 #.N,*KD\'/&1GKQUU<N/"#2MJBWNHFYCU'<)6,
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MC_WY?_XFCV-3^5_<'M8=T;]%8'_":Z!_S_'_ +\O_P#$T?\ ":^'_P#G^/\
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M (FC_A-= _Y_C_WY?_XFCV-3^5_<'M8=T;]%8'_":Z!_S_'_ +\O_P#$T?\
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MJ2@HHHH **** "BBB@ HHHH \VU^XT >(;M;%W;5 X^T"YE*VH;CJ788./\
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MN[9*C%*R15_LRP_Y\;;_ +]+_A1_9EA_SXVW_?I?\*M44N9]QV78J_V98?\
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M10!YA\:X=6;PNDT%Y;II:SP"XMVBS)(WG+M*MV XKT^N!^,G_).KC_K[M?\
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MZ4 =)16)X>\20:['-#)"]GJ=J0EY8S']Y"WK_M*>H8<$?E6W0 4444 %%%%
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M/[J[C'_+6(GJ/5>J]_6NEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;.&R6:+S,CTQD5PVJ>$=<N]3U.4O:3F\L9H_/"E&9O,1HXSEC@ +C@8ZGJ:
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MY%Q);H\L6,;&*@D8[?2@"]1110 4444 <#\9/^2=7'_7W:_^CDKOJX'XR?\
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M8VZJ2,X/TH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ?\ 1/O$_P#WY3_XJC_A8NJ?]$^\3_\ ?E/_ (J@#O:*X+_A8NJ?]$^\3_\
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MJ?\ 1/O$_P#WY3_XJC_A8NJ?]$^\3_\ ?E/_ (J@#O:*X+_A8NJ?]$^\3_\
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M,['3PK;3YI(DR$P-G12&$AR.N^NJH *I:EJEOI<<33B1WFD\J&*)"[R-@G
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M.AHK#N/%^BVNHSV,MT_GVX!FVPNRQKQ\S,!@ 9&3GC/-.OO%.F6+W,3/))+
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M"994*2/L&67&,$^E7** *']B:7Y447V"W\N%BT:^6,(3U(].E..D:<SSL;*
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4NP<&)0NWKWQUK=HHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
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M =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\
M"M>B@#(_X17P[_T =+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\
MT =+_P# ./\ PH_X17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH
M_P"$5\._] '2_P#P#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =
M+_\  ./_  K7HH R/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#
M(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T
M=+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X
M17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P
M#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R
M/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\
MP#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T =+_\ X_\*/\ A%?#
MO_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X17P[_P! '2__  #C
M_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^$5\.
M_P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R/^$5\._] '2__ ./
M_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\
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M):6HNKC>+2)QM98^..,#)R<#%6X/!&EV\'AV))+K;H!)M,N/FRNWY^.>/3%
M'-Z9\3=1NY-.DNO#\<%G<ZH=(EE2\WLMP"1E5VC*<=20?:G0_%%I/&=MHITV
M![2XO7LDN8+HR%'4'&[";.<'@.2.XK<A\ :1!:VUNDMWLMM6.KH3(,^<23@_
M+]WD\=?>JMM\,M&M-0L[J&]U0)97C7MK:FX!AA=B2P5=O0Y/4D^A'- &7IWQ
M-O[N73)KC08XM.OM5?2EG6\W.) Q"MLVCY?EYYS6II7C74]9U#SK/P^9="^V
MO9?:UN1YJE"09#'C'EY!'WL]\59A^'VCP6.GVB2WGEV.IG5(B9!DS$DX/R\K
MECQ^M)#\/M(@U?[;'<:@L NS>C3Q<?Z,)SU?;C.<\XSC/:@#"\/_ !:@U[Q#
M:V,>G@6=Y-)#!*DC-*A7.&E78%56QQACU&:V=;\8ZA;:]=Z1HFC)J,]A:+=W
MC2W/DJJG.U$^4[G(!/.![U/I7@'2M'U.&[MKC4##;O)):V+W!-O;L^=Q1,>Y
MX)(&3C%2:YX(T[7-2;4#=ZA8W4L'V:X>QG\OSXO[CY!R.3R,'GK0!QT7B;5?
M%7Q(\-C3II8=#GTS^T1$ET8F?YP&\P!3N(/R[,X/7(JM\4?&%]8^)$LM+UR+
M3FTBS.HSQO,$^V/O7;!@GYB5#''N*] L_!VDZ=K5CJ=FDD+V5A_9\$*L/+6+
M<&Z8SG(ZYJN/ 'AR35-2U&_TZ'4KJ_E$DCWT:2^7@8"ID?*H% %.[\=2SWVB
M6/A_34U&YU2S-^/-N/)2. 8YW;3EB3@#'7KBN>\"^-[Z#0=!.N&26'4;F]BD
MOKB;)@DC9V5&XP055@#G^&NAA^&FD6MEI=O:7^JVTFF>8MM<PW(658Y#EHB=
MO*>G&1V-.?X::#)X&/A%VO&T_P TS+(TH,JN7+Y#8]21TZ&@#+D^)ER?"^G:
MQ%I5NC:G<2K9PW%T59XE)VOM5&<LV.BJ<9&33;/XFWNJVGAEM-T%'N=<%ROE
M3W7EB%H>N6VG(Z]L^U=%J?@C3-1_LAHI[W3Y=)0Q6DUE*(W6,J%*<@\$ >_H
M:@TGX>:-HTFBM:RWA_L=[AK422AA^^^\&XR0.W]: ,FT^)-SJ6F:.MEHRMK6
MIW-Q;):RW.V*-H,^8QD"DD8'&%R<TFM_$RXT2WTN"\T=;/5KT2L\%Y<%8HA&
M<$[T1BP8XV_+]<5J?\*XT=--MK6"YU"WEM;N6\M[R*8+-"\A)?!VXVG.,$'B
MA_AUI/V2Q2WO-3M;NR,ACOX;K_2&\SF3<Q!!W?3CMB@"A;_$:YU8:%!HNAM+
M?ZG;R74D%W/Y MXXVVMD[3DEN!Q[\5SMIXAUE_V?]5UB2_NEU.-KC;.TF9(\
M3D ;O8<5VUQX TF6+2A;7&H6,VEHT4%S:W)$I1OO*S,#N!//KGIBB#P!I%OX
M&G\(I+>'3I]^YVE!E^9]Y^;'K[4 >1:WXT\2?\(QI&G0:Q<QZGI<A.JSQR$/
M(IE1(PWU$F>?2N\M/'4UO=ZE96=A/=ZC<>()].M8KJ^)CRB!F;<5_=H!_" :
MV;OX8^'[R35I'-VKZH+83E) -OD%2FWY>,[1GKGVJ2;X=:-*EUMGOH;B?4VU
M1+F*8+)!.P )0XP!@8P0: *-_P".-=LWT.Q/AE(]5U.XGMC!/>;8U,:[MZN%
M.Y".>@/M45]\1[VT_M6\BT-9])T6=;;4;@76'$F%W^4FWY@NX=2N>U;%IX!T
MFTN=*N1/?2W&G7$UTLLTV]II95VNTA(YX], 5'J'PZT;4M0N[B2:_CM[Z59K
MVPBGVV]TZXP77&>PS@C..<T 4?B/=7DMAX<M]-U2[L%U'5H+=[BT?8_ENK=/
MT-8I\0WOPXUW5M/U75KW7--BTG^TXFN2#.C^:(]FX 9#$C&>E=OXI\)6/BS3
M[:SN[B\M1;3K<0RV4HBD1U! (.#CKVK-L?AIH-KI^I6MTU]J;ZE$(;FYU"Y:
M69D'*J&XP >1CN!0!B67Q3N;S1]9N8M&CGNM,MUN]EO.[12Q9^<!VC4[U&21
MC![&CQ/\0XY=-\1C3[>::QTRP@GEN[:[,+F65E*QHP4X^4Y)_#%=;HGA.ST5
MKJ0WE_J$UTBQ22W\_FMY:C 0#  ')[9/<FLNT^&7A^Q\&ZAX7MQ=)87\ADF<
M2#S,Y! #8Z#: ..E $(\:ZI/JEY;:1X?;4+33)(H;R3[4%F+NH)\M",-M# G
M)7/.*S;GXMV\/BJ;3(]/$EK;WPL97$C>=OR SA FTHI."2P/!.*W;[X=Z1?:
MC-=FZU&!+KRS>6T%SLBNC'@*7&,YP!G:1G'-/;P!I)UI]02XU"**2Z%[+8QW
M!6WDG'_+1EQG/ R,X.!D&@#)LOB/->>-)M!.FVUNL5VUMMN;WRKEE'_+58V4
M!T/;:Q/M71^-;J>R\#:]=6LSPW$-A-)'(APR,$)!!]:HW7@#3K_5H;V\U#5;
MF&&Z%W%937.^%)0<@C(W  \[=V/:K,'AEYM"UO2M4OKBXAU2:X)/FEFABDXV
M*2. !T&,#- '&V_Q%UBSTLP0Z1'J#Z=H5KJ5U<SWGEM(&CRW&TY;@GWYZ5MS
M>/;^]O([7P]H7]H2KIT6I7"RW(A*I(,K&G!W.1GK@>]7H_A]H\<-]$LMYMO=
M,CTN7,@R(44J"/E^]@]?TJ.\^'.DW2VWE7NIV;PV*:?)):7&QKB!1@))P<_4
M8/)YH T?$3ZU=^$9GT*,P:I/$OEQS8#(6P""=PVD9SD$XQP#5OP]_:9T"R_M
M@*-1\L>>%& &].IS]<\]:33]"M],OFN+:XNQ%]GCMDM6F+0QJG0JIZ,>YSS@
M5J4 %%%% !1110 4444 %%%% !1110 4444 >=_&7_D4+3_K_3_T7)11\9?^
M10M/^O\ 3_T7)10!UOA7_D4-$_Z\(/\ T6M:]9'A7_D4-$_Z\(/_ $6M:] !
M1110 45RNO:KJ6AZE!<M<&2RFE*>5Y2B- (V(4M][S&<#'\.#C&>3DMXCUFU
MMX(WNUFEO[*VN$E,*@6[RS+&P  Y4!\C=DY7DF@#T"BL70+VZGEU2SNY3.]C
M=F%9R@4R*41QD# R-^. .E/N/$FFVMZ+.X:YCF.XH&M)<.%QN*G;A@,CIZT
M:]%9/_"2:9_?N/\ P$E_^)H_X233/[]Q_P" DO\ \30!K45D_P#"2:9_?N/_
M  $E_P#B:/\ A)-,_OW'_@)+_P#$T :U%9/_  DFF?W[C_P$E_\ B:/^$DTS
M^_<?^ DO_P 30!K45D_\))IG]^X_\!)?_B:/^$DTS^_<?^ DO_Q- &M163_P
MDFF?W[C_ ,!)?_B:/^$DTS^_<?\ @)+_ /$T :U%9/\ PDFF?W[C_P !)?\
MXFC_ (233/[]Q_X"2_\ Q- &M163_P ))IG]^X_\!)?_ (FC_A)-,_OW'_@)
M+_\ $T :U%9/_"2:9_?N/_ 27_XFC_A)-,_OW'_@)+_\30!K45D_\))IG]^X
M_P# 27_XFC_A)-,_OW'_ ("2_P#Q- &M163_ ,))IG]^X_\  27_ .)H_P"$
MDTS^_<?^ DO_ ,30!K45D_\ "2:9_?N/_ 27_P")H_X233/[]Q_X"2__ !-
M&M163_PDFF?W[C_P$E_^)H_X233/[]Q_X"2__$T :U%9/_"2:9_?N/\ P$E_
M^)H_X233/[]Q_P" DO\ \30!K45D_P#"2:9_?N/_  $E_P#B:/\ A)-,_OW'
M_@)+_P#$T :U%9/_  DFF?W[C_P$E_\ B:/^$DTS^_<?^ DO_P 30!K45D_\
M))IG]^X_\!)?_B:/^$DTS^_<?^ DO_Q- &M163_PDFF?W[C_ ,!)?_B:/^$D
MTS^_<?\ @)+_ /$T :U%9/\ PDFF?W[C_P !)?\ XFC_ (233/[]Q_X"2_\
MQ- &M163_P ))IG]^X_\!)?_ (FC_A)-,_OW'_@)+_\ $T :U%9/_"2:9_?N
M/_ 27_XFC_A)-,_OW'_@)+_\30!K45D_\))IG]^X_P# 27_XFC_A)-,_OW'_
M ("2_P#Q- &M163_ ,))IG]^X_\  27_ .)H_P"$DTS^_<?^ DO_ ,30!K45
MD_\ "2:9_?N/_ 27_P")H_X233/[]Q_X"2__ !- &M163_PDFF?W[C_P$E_^
M)H_X233/[]Q_X"2__$T :U%9/_"2:9_?N/\ P$E_^)H_X233/[]Q_P" DO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVU 9ST:/C./]CMC]30=*E.?^)MJ SGHR<<Y_N?A^-:5% &=_9<N<_P!K7_\
MWTGKG^Y^'TH&E2@C_B;:@<8ZLG/.?[GX?2M&B@#-&E2C'_$VU XQU:/G&?\
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MK*C/^@:@<9Z6S<XQ_C0=94$C[!J'&?\ EV;UQ_\ 7^E:5% &:-94G'V#4/\
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MRJY_T#4#C/2V;G&/\?YT'65!/^@:AQGI;-V./_K_ $K2HH S?[97./L&H?\
M@,WKC_Z_TH&LJ2/] U 9QUMF[G']*TJ* ,T:RK8_T#4!G'6V;C.?\/Y4@UE2
M!_H&H\XZVS=QG_/O6G10!F?VTN,_V?J/3_GV;TS_ /6^M!UE0#_H&HG&>ELW
M89_K^=:=% &:VLJN?] U XSTMFYQC_'^=!UE03_H&H'&>ELW8X_K^5:5% &;
M_;*YQ]@U#_P&/KC_ .O]*RM0U@G5=/F6SO0D3@,K0E<^8=@_+D_C73UB:K+Y
M)U"X*LWV>&&3:O4A79B/TK2G\1$]BRNLJV/] U 9QUMFXSG_  _E2#65./\
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M*/C+_P BA:?]?Z?^BY** .M\*_\ (H:)_P!>$'_HM:UZR/"O_(H:)_UX0?\
MHM:UZ /./%7A::[U^YO&\)-K$4^W$EMKDMLXPH&'C+!.W53SW%=9X7BOX-*6
MWN])M-)@A"I;6=O/YIC0#HQP!GZ9^M<_\1M5\2:7)I$FC)=&R,_^F-9VXFE(
M#+QM/0;?,.1W '&:Z3PM<:G=^&-.N-90)J$D(:8  <]B0. 2,$@=#F@#7HHH
MH *Y_4O^1YT#_KUO/_:-=!7/ZE_R/.@?]>MY_P"T: .@HHHH **** "BBB@
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MV<5<BZD['F7B?X)Z/XH\0W6L7.L:K%+<L&:-)%*K@ 8&5) XZ5M:3\-[#2/
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MG'6RE'7/^S[4#6+<@?N+[G'_ "Y2^F?[O^>E2,T**S_[8M\9\B^_\ I?3/\
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M+3_K_3_T7)10!UOA7_D4-$_Z\(/_ $6M:]9'A7_D4-$_Z\(/_1:UKT %%%%
M!7"3>$+Z8A[>UT_3VMP&$=L2([N194D4OQD?<(YR1O/X]W10!CZ%I]S:-J-W
M>+''<7UUYYBC?<(P$5 ,X&3A,GCO6+K.FW3^-=($&K7<3RP7;!B$81C]UE5&
MWW'7/05V5<_J7_(\Z!_UZWG_ +1IIV E709Q*RMJ]X;8 -&I*EED[MD@_7'K
M5&*UO;2^6UGU"^BM)'>*!@T><XW _<Z8SCW!]174U4U'3;75;9;>[0O&KK(
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ML?K0=+F)/_$VOQU[Q^N?[GX?2M&B@#._LN;.?[6O_P X_7/]S\/I0-+F&/\
MB;7YQCJ8^<$G^Y[X_"M&B@#.&ES#'_$WU XQU,?.,_['?/Z4@TJ8 ?\ $WU
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MH **** "N?U+_D>= _Z];S_VC705S^I?\CSH'_7K>?\ M&@#H**** "BBB@
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M8W_0NZ__ . @_P#BJZ*B@#G?^$L;_H7=?_\  0?_ !5)_P ):P'_ "+NO_\
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M .=_X2QO^A=U_P#\!!_\51_PEC?]"[K_ /X"#_XJNBHH YW_ (2QO^A=U_\
M\!!_\54<'C-+F!)X- UYXI!N1A:#!'K]ZMVZU&RL9(8[N\@@>=MD2RR!3(WH
MN>IJ2VMX;2VCM[>,1PQKM1!T H PO^$L;_H7=?\ _ 0?_%4?\)8W_0NZ_P#^
M @_^*KHJ* .=_P"$L;_H7=?_ / 0?_%4?\)8W_0NZ_\ ^ @_^*KHJ* .9D\9
M)$\22>']>5I6V(#:#YFP6Q][T!/X5)_PEC?]"[K_ /X"#_XJM6&YTW59-T%Q
M;W3V<O/ER!O*DP5YP>#AB/QJ[0!SO_"6-_T+NO\ _@(/_BJ/^$L;_H7=?_\
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M?_A+&_Z%W7__  $'_P 51_PEC?\ 0NZ__P" @_\ BJZ*B@#G?^$L;_H7=?\
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MT+NO_P#@(/\ XJMV"VAM@XAC"!W:1L=V8Y)_.I: .=_X2QO^A=U__P !!_\
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M-QV;R."VW;DCOFJ]OX6LH]=_MF>2>ZNQ%&B^<1L5U7;Y@4 #>1QGMVQDUNT
M%%%% !7,>(O$>HZ3<SM:V$4EI90)<W4DS,ID1F(*Q8&-P"DG/J!WS5[Q)KHT
M+2+BZCC$T\:@[.H12<>8X'.Q>I([ UB+::OXE%]INL71MX6L]D<MA&#!<;SD
M3*[9^88'R'IURP(H NZ5X=.@:@AT.Y!L)'87UK,Y;]X?F\U3_"Y)&X=""#P1
MST]4M+TNUT>Q6UM5.W)9W<[GD<_>=F[L3U-7: "BBHIKJWMVQ-/%&=C/AW ^
M5?O'GL,\GM0!#J=W)8:7=W<5L]S)#$TBPQ_>D(&0H^M<>]G+X@U21=:N8K+5
M=+5/L-Y9N45&G (^5^2V4*E3PP/09X-9UK5+37;Q-,FF+30J?L\J>;^[P!]I
MM@#\^W/S1YST/?YMZ#PM9#6TUFXDGNKM88T'G$; Z@CS=H &\@D9[=L<T :>
MG&^.GP_VDL O ,2^024)!ZC/(!ZX[9QS5JBB@ HHK'\2:X-"T>ZNXXC<3Q1[
MQ$O)4$XWL!SL&<D@= : ,WQ7KFH6 NHK2QCEM;>T^T7<DKLA>,DJ5B(&-X )
MY]O7(HBRO=+\66EIH-DKPKID5J]W+CRX51\G?C!+[2-J\?>)X%3+;:MXC^UZ
M=JUUY-N]BRQRV$>8+D2=)0[9P5&/D_'+ C'1Z1I%KHMB+6U#'+%Y99#N>9S]
MYW;NQ]?Z4 7Z*** "JVH73V6FW5U' ]P\,32+#']Z0@9VCW/2GS75O;L%FGB
MB8JS .X4D*,L>>P[^E<5K6N:G9:]=#3))6,UN&6WE7S5=,#_ $BV /SE<_/'
MG)&"/< S]62YU"V\2/J]O;2:C'I420" ':1(79557Y\S>I'!^;Y> 17=:+<:
MA=V/VC4+46ID;,,!.9$CP,>8>F\\D@=,XYQ5&#PM9-K-OK-U-/=W4=O'&/.(
M"%USB4H !OPQ&>V>,5OT %%%% !7,>*-<U'3C/'96,4L%M9M=W3S.R;HP2"D
M; 8WX!//3CUXTO$&M+HFD75VD1N)H8C((4Y;&<;B!SM&<D@' S6##%J_B1KC
M3]5N5CM)+%Q'/I\>;>[608$@9B2"H/W._7)'  (3H36>M:;_ &"M^ABCMHI9
MA.@@$*9RLJ=6<JQQQU8'(P:[FL_1]'MM$L!;6V]R3OEFD.Z29SU=SW)_^L.!
M6A0 445%+<P0,JS3QQLP)4.X!( R2,^@ZT -O;AK2PN+E(7G:&)I!$GWG(!.
MT>YZ5P-W;G69]1'B*#_25L+9XC8':P1Y"P11)TEW)C((SD< BKFN:YJ-EKDQ
MTJ61VFM@T=M*!)'/'C_76V#\SIGYH\C<,$=B=F#PO9S:K9ZS>3W%Y=0VT<:^
M=A49EW$2E  -_P [?3/ % $WA>+48M&VZD]PS^:YA^TE3,L6?D$A7@MC_P"O
MS6U110 445EZ]K"Z+I-U=K"US/%$9%MX^78#OCK@9R2,X% &?XDUW4],DD73
MK*&5;:T>]G>X+*K(IY1"!]\C)YX''KQB6>@:L?%UQJNDW$%E9RSI<SKOW&]5
MU4E'4?<*_,0W4Y Z5<MO[7\1.]CJ5RB6,UE(4N-.CS!=K(NT-N;)4J#]WOP<
MXX'0Z)HMMH5@+:W,DCL=TUQ*=TDSXP68]SQ] , <4 :5%%% !3)I##!)*$:0
MHI8(O5L#H/>DDGBB9%DE1&D)"!F +$#) ]> 3^%<;KVMW]GK<<VE2/,9K;,5
MM(P>&]4 DM 0?]:N<E<C>O3ID &5K5QJ?B"PBM-5TZS:14M]3@B69K<QAG*%
M'=ONNNX$,,<@X&>O:>&[/6+#21;:W?QW]VCG%RB[=Z]LC'!'3WQGO5*W\,6U
M_<:9JNHW-Q?7,%NH_?*(TD;.\.T>."I)P#T^HS724 %%%% !6!XBU?4["1(-
M+LX99/(EN7DN2RQ[8\90$#[YW<9X&">:T-8U1=)TVXNA#)<S1Q-(EM#S)+M&
M2%'?\*YS3KK6-?FM8KZXA_LZ>V>9+C3HRT-R&7;L9FR4*[B<?Q<'C!6@#(MM
M$N4AM&T:74'>9X[JQ*3A(K"-R'9)5W?O-VY^2I)&!GC->DUD>'?#UIX<TX6U
MN\DTK >=<S',DS 8!8^P   X Z5KT %%%1R3Q1/&LDJ(TC;4#, 7.,X'J< G
M\* '2,4C9@I8J"=HZGVKS>[DU/6-3L[K4G33I([$WB_9]RR+;NP$D!+D;9?N
M .-O\0K5U_7+VTURWGTJ1YC+;GR8'<-;WPY)$3 \3+UQQO'';(O6_ABWU-]*
MU75+FYO;B&W&Y98_*25BP=6>/'!4]%/3ODC- %CPG#>PZ?<"Z6\CMVG+6D5]
M)OGCBP/E=LG^+=C)) QDUOT44 %%%% !1110 4444 >=_&7_ )%"T_Z_T_\
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M;:TA2&($MLC7:H).3@=N23@5'IFDZ?HUL;?3K2*VB9BY6,8R3W-7: "BBB@
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M.=PZ\?KTKG_"7A<FRLK[4?M"F*5YXK&1 D2298"81XS&S*=VP'"EC@"NVHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'G?QE_Y%"T_Z_T_]%R44?&7_D4+3_K_ $_]%R44
M >-V/B;7XM/MHX]<U)(TB555;N0!0 , #-6/^$J\1?\ 0?U3_P #)/\ &BB@
M _X2KQ%_T']4_P# R3_&C_A*O$7_ $']4_\  R3_ !HHH /^$J\1?]!_5/\
MP,D_QH_X2KQ%_P!!_5/_  ,D_P :** #_A*O$7_0?U3_ ,#)/\:/^$J\1?\
M0?U3_P #)/\ &BB@ _X2KQ%_T']4_P# R3_&C_A*O$7_ $']4_\  R3_ !HH
MH /^$J\1?]!_5/\ P,D_QH_X2KQ%_P!!_5/_  ,D_P :** #_A*O$7_0?U3_
M ,#)/\:/^$J\1?\ 0?U3_P #)/\ &BB@ _X2KQ%_T']4_P# R3_&C_A*O$7_
M $']4_\  R3_ !HHH /^$J\1?]!_5/\ P,D_QH_X2KQ%_P!!_5/_  ,D_P :
M** #_A*O$7_0?U3_ ,#)/\:/^$J\1?\ 0?U3_P #)/\ &BB@ _X2KQ%_T']4
M_P# R3_&C_A*O$7_ $']4_\  R3_ !HHH /^$J\1?]!_5/\ P,D_QH_X2KQ%
M_P!!_5/_  ,D_P :** #_A*O$7_0?U3_ ,#)/\:/^$J\1?\ 0?U3_P #)/\
M&BB@ _X2KQ%_T']4_P# R3_&C_A*O$7_ $']4_\  R3_ !HHH /^$J\1?]!_
M5/\ P,D_QH_X2KQ%_P!!_5/_  ,D_P :** #_A*O$7_0?U3_ ,#)/\:/^$J\
M1?\ 0?U3_P #)/\ &BB@ _X2KQ%_T']4_P# R3_&C_A*O$7_ $']4_\  R3_
M !HHH /^$J\1?]!_5/\ P,D_QH_X2KQ%_P!!_5/_  ,D_P :** #_A*O$7_0
M?U3_ ,#)/\:/^$J\1?\ 0?U3_P #)/\ &BB@ _X2KQ%_T']4_P# R3_&C_A*
MO$7_ $']4_\  R3_ !HHH /^$J\1?]!_5/\ P,D_QH_X2KQ%_P!!_5/_  ,D
M_P :** #_A*O$7_0?U3_ ,#)/\:/^$J\1?\ 0?U3_P #)/\ &BB@ _X2KQ%_
MT']4_P# R3_&C_A*O$7_ $']4_\  R3_ !HHH /^$J\1?]!_5/\ P,D_QH_X
M2KQ%_P!!_5/_  ,D_P :** #_A*O$7_0?U3_ ,#)/\:/^$J\1?\ 0?U3_P #
M)/\ &BB@ _X2KQ%_T']4_P# R3_&C_A*O$7_ $']4_\  R3_ !HHH /^$J\1
M?]!_5/\ P,D_QH_X2KQ%_P!!_5/_  ,D_P :** #_A*O$7_0?U3_ ,#)/\:/
M^$J\1?\ 0?U3_P #)/\ &BB@ _X2KQ%_T']4_P# R3_&C_A*O$7_ $']4_\
M R3_ !HHH /^$J\1?]!_5/\ P,D_QH_X2KQ%_P!!_5/_  ,D_P :** #_A*O
M$7_0?U3_ ,#)/\:/^$J\1?\ 0?U3_P #)/\ &BB@ _X2KQ%_T']4_P# R3_&
MC_A*O$7_ $']4_\  R3_ !HHH /^$J\1?]!_5/\ P,D_QH_X2KQ%_P!!_5/_
M  ,D_P :** #_A*O$7_0?U3_ ,#)/\:/^$J\1?\ 0?U3_P #)/\ &BB@ _X2
MKQ%_T']4_P# R3_&C_A*O$7_ $']4_\  R3_ !HHH /^$J\1?]!_5/\ P,D_
MQH_X2KQ%_P!!_5/_  ,D_P :** #_A*O$7_0?U3_ ,#)/\:/^$J\1?\ 0?U3
M_P #)/\ &BB@ _X2KQ%_T']4_P# R3_&C_A*O$7_ $']4_\  R3_ !HHH R?
>$.OZS>Z?''=:M?SQB4,%EN78 X/."?<T444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
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M =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\
M"M>B@#(_X17P[_T =+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\
MT =+_P# ./\ PH_X17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH
M_P"$5\._] '2_P#P#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =
M+_\  ./_  K7HH R/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#
M(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T
M=+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X
M17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P
M#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R
M/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\
MP#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T =+_\ X_\*/\ A%?#
MO_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X17P[_P! '2__  #C
M_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^$5\.
M_P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R/^$5\._] '2__ ./
M_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\
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M2:9_?N/_  $E_P#B:/\ A)-,_OW'_@)+_P#$T :U%9/_  DFF?W[C_P$E_\
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MN/\ P$E_^)H_X233/[]Q_P" DO\ \30!K45D_P#"2:9_?N/_  $E_P#B:/\
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M"JNYD=F<NSL>K,Q))/UK)U+_ )'G0?\ KUO/_:-=!7/ZE_R/.@?]>MY_[1H
MZ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[WH T:*SAH=BN,"XXQC_ $J7MG'\7O2#0K$  "YXQ_R]R]AC^]Z4 :5%9O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_(+BQ_U]>^/[OIS^E N]6.,Z7$.F?]+Z<G/\/IC\ZTJ* ,T7>K'&=*B'3/\
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M;B.2)Q&7(1Y%/7:-P[@@\&NJ\&6"Z9X/TRS2"Z@$46#'=JJR@Y).X*2!DDG
M. "*XOQ/='6_B!8VN-3L+>QN?[.74K"\2.3SYHA+M*%#E-J@9SU[<5Z/IUFV
MGZ?#:-=W-V8EP9[E@TC\]6( !/X4 6J*** "N?U+_D>= _Z];S_VC705S^I?
M\CSH'_7K>?\ M&@#H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEQY:LPVX'48^;UQ5_P"%7AMM"T*XN/M,,L-\Z21+#:M;JH50N2C $,2#GCG
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M+-DLQAASG&2>GH<TW+WKDI:6,^[\;^']*\/6NLZGJ&VROK")(I-C.TC'?D8
MSGKFLKPWX[\&^*?%5O!#J32WDL)BC@EMW59#L7/)&,C:W!K:T:V\/S:/)INL
M#2;B"SD\B**?RVCV1@88!O\ >//O4WA_0_"&@,TT$6B17:S2E)T$0D12Q &X
M<C ('XXK63<6TF0DI)71#K?Q:\&>'M6GTO4-3=+NW.V1$MY'"G&<9 Q6EI_C
M[PUJ?ABZ\1VNHAM+M"5GE:-E*$8X*D9SR.W<47NE^"=2NWNKZST&YN7^_+-'
M"[M@[>2>3SQ^E6+>/PK;::^FVRZ/%8RYWVT?E"-]QQRHX.2,?A6!J<S!\;_
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MK%V<8SF.'GK_ +'?^E T^\&,ZS=GI_RSAYXQ_<_'\*0S0HK._L^\Q_R&;O\
M[]P^F/[GKS_];B@Z?>'/_$YNQU_Y9P\<8_N?C0!HT5GG3[PYQK%V,YQB.'CI
M_L=OZT&PO#G&L78SG_EG%QSG^Y^'XT :%%9_V"\S_P ABZ_[]Q>N?[GIQ_\
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MH **** "N?U+_D>= _Z];S_VC705S^I?\CSH'_7K>?\ M&@#H**** "BBB@
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M@N,D#)P,GK5!=.GA?;;7\L=N3G85#E?92>@]B#2C2XY<F\D>[;MYH "\8R
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M08(/0_>K=N-1L;2X@M[F\MX9YSB*.20*TA_V0>M26]O#:6T=O!&(X8U"H@Z
M#M2&87_"6-_T+NO_ /@(/_BJ/^$L;_H7=?\ _ 0?_%5T5% '._\ "6-_T+NO
M_P#@(/\ XJC_ (2QO^A=U_\ \!!_\57144 <RWC1$GC@;0-=$L@)1?L@RP&,
M_P 7N*D_X2QO^A=U_P#\!!_\56S&+.^>&]B:*<Q[UCE1MP&3A@"/<8/TJS0!
MSO\ PEC?]"[K_P#X"#_XJC_A+&_Z%W7_ /P$'_Q5=%10!SO_  EC?]"[K_\
MX"#_ .*I/^$M8#_D7=?_ / 0?_%5T=1O+$)%@>1!)("50L,L!UP.^,C\Z .=
MA\9+<01SP^']>>*10Z,+088$9!^]4G_"6-_T+NO_ /@(/_BJWH((K:WBMX4"
M11($11T50, 5)0!SO_"6-_T+NO\ _@(/_BJ/^$L;_H7=?_\  0?_ !5=%10!
MSO\ PEC?]"[K_P#X"#_XJHW\9I%+%$^@:ZKRDK&IM!\Q )/\7H":Z:LVTO\
M2-9N2]I=6UW-8R$$Q2!C$Q!!SCU&10!G_P#"6-_T+NO_ /@(/_BJ/^$L;_H7
M=?\ _ 0?_%5T5% '._\ "6-_T+NO_P#@(/\ XJC_ (2QO^A=U_\ \!!_\571
M44 <[_PEC?\ 0NZ__P" @_\ BJC@\9I<P)/!H&O/%(-R,+08(]?O5MW>IV&G
MR01WE[;V[W#[(5ED"F1O09ZU-;6\-I;1V]O&(X8UVH@Z 4 87_"6-_T+NO\
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MK>3$L=S'C_76V#RZ9^:/(WK@CUK;@\+V4FJV>L7<UQ>7<-M'$IG("EEW$2E
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M4-AI]GI=FEI8VT=O;IG;'&N ,\F@!]I:6]A:16EK$L5O$H6.->BCT'M4U%%
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MHH XGPIX7W6EM?:B+I62=YTM)55(R^2%G,6/DD*_,5!P&). :[:BB@ HHHH
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M5>(O^@_JG_@9)_C1_P )5XB_Z#^J?^!DG^-%% !_PE7B+_H/ZI_X&2?XT?\
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M5XB_Z#^J?^!DG^-%% !_PE7B+_H/ZI_X&2?XT?\ "5>(O^@_JG_@9)_C110
M?\)5XB_Z#^J?^!DG^-'_  E7B+_H/ZI_X&2?XT44 '_"5>(O^@_JG_@9)_C1
M_P )5XB_Z#^J?^!DG^-%% !_PE7B+_H/ZI_X&2?XT?\ "5>(O^@_JG_@9)_C
B110!D^(=?UF]T^..ZU:_GC$H8++<NP!P><$^YHHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 21, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000312070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BARCLAYS BANK PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-287303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Oct. 21, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Global Medium-Term Notes, Series A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 928,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 128.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 21, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 928,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">128.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">128.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 928,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236099_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236099_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236099_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236099_exfilingfees.htm">dp236099_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236099_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236099_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2025": 1,
    "http://xbrl.sec.gov/ffd/2025": 6
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 24,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236099_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236099_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236099_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236099_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236099_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236099_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000950103-25-013455-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-013455-xbrl.zip
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M_ =02P$"% ,4    "  .@%5;MUA(*+$*  !]-P  &0              @ $
M    9' R,S8P.3E?97AF:6QI;F=F965S+FAT;5!+!08      0 ! $<   #H
%"@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>dp236099_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-21</startDate>
            <endDate>2025-10-21</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
        </entity>
        <period>
            <startDate>2025-10-21</startDate>
            <endDate>2025-10-21</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0000312070</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-287303</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_010">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_011">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="fee_013">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_014"
      unitRef="shares">928</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">928000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-223"
      unitRef="USD">128.16</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-224"
      unitRef="USD">928000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-225"
      unitRef="USD">128.16</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-226"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-227"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-228"
      unitRef="USD">128.16</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-230"
      unitRef="USD">928000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-231">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
